Patent Grant
9275451
The present invention, in some embodiments thereof, relates to a system and a method for analyzing a multidimensional patient profile and, more particularly, but not exclusively, to a system and a method for analyzing a multidimensional patient profile that includes a medical image.
Systems and devices for visualizing the inside of living organisms are among the most important medical developments in the last thirty years. Systems like computerized tomography (CT), magnetic resonance imaging (MRI), a positron emission tomography (PET), and a single photon emission computed tomography (SPECT) scanners allow physicians to examine internal tissues or areas of the body that require a thorough examination. In use, the visualizing scanner outputs a 3D medical image, such as a sequence of computerized cross-sectional images of one or more tissues, which is then interpreted by specialized radiologists.
It should be noted that other imaging devices and methods are also known, for example as disclosed in International patent application Pub. No. WO2006/051531, which has been published on May 18, 2006 and incorporated herein by reference. This patent application describes an apparatus for radiation based imaging of a non-homogenous target area having distinguishable regions therein. The apparatus comprises an imaging unit designed to obtain radiation intensity data from the target region in the spatial dimensions and one or more other dimensions. The apparatus further comprises an image four-dimension analysis unit associated with the imaging unit for analyzing said obtained intensity data in the spatial dimension, and the one or more other dimensions, in order to map the distinguishable regions.
Commonly, a patient is referred for a visual scan by a general practitioner or an expert practitioner. The 3D medical image is forwarded to and diagnosed by a general radiologist who is responsible for the analysis and diagnosis of the medical image. The medical images and the diagnosis thereof are sent back to the referring practitioner.
In most hospitals and radiology centers, the 3D medical images are transferred to a picture archiving communication system (PACS) before being accessed by the radiologists. The PACS is installed on one or more of computers, which are dedicated for storing, retrieving, distributing and presenting the stored 3D medical images. The 3D medical images are stored in an independent format. The most common format for image storage is digital imaging and communications in medicine (DICOM).
Typically, a PACS network consists of a central server that stores a database containing the images connected to one or more clients via a local area network (LAN) or a wide area network (WAN) which provide or utilize the images. Web-based PACS is becoming more and more common: these systems utilize the Internet as their means of communication, usually via a virtual private network (VPN) or a secure sockets layer (SSL). The software in thin or smart client is loaded via ActiveX, Java, or .NET Framework. Definitions vary, but most claim that for a system to be truly web based, each individual image should have its own URL. Client workstations can use local peripherals for scanning image films into the system, printing image films from the system and interactive display of digital images. Modern radiology equipment, modalities, feed patient images directly to the PACS in digital form. For backwards compatibility, most hospital imaging departments and radiology practices employ a film digitizer.
Computer aided detection (CAD) systems that assist physicians in diagnosing pathological, traumatic, or healthy indications are known. However, these CAD system are usually based on fixed expert rules and a closed list of treatments. For example, U.S. Pat. No. 6,188,988 and U.S. Pat. No. 6,081,786, which have been granted on Feb. 13, 2001, disclose systems, methods and computer program products for guiding selection of a therapeutic treatment regimen for a known disease such as HIV infection, are disclosed. The method comprises providing patient information to a computing device (the computer device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for the disease; a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for the disease; and a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of the different therapeutic treatment regimens; and generating in the computing device a listing (preferably a ranked listing) of therapeutic treatment regimens for the patient; and generating in the computing device advisory information for one or more treatment regimens in the listing based on the patient information and the expert rules.
According to one aspect of the present invention there is provided a method for analyzing a functional map of at least one tissue of a patient. The method comprises managing a plurality of functional maps each being associated with a plurality of first biological activity indications, receiving a functional map being associated with a plurality of second biological activity indications, identifying a matching set of the managed functional maps by matching between the plurality of first and second biological activity indications, and using the matching set for a member of a group consisting of: an image data acquisition, a diagnosis of the received functional map, a classification of the received functional map. Optionally, the received functional map is associated with first medical information related to the current patient, each the managed functional map being associated with second medical information, the matching comprises matching between the first and second medical information.
Optionally, the received and managed functional maps are pixelated.
More optionally, at least some pixel elements of the received pixelated functional map is associated with the plurality of first biological activity indications, at least some pixel elements of each the pixelated functional map is associated with the plurality of second biological activity indications, the matching being between respective pixel elements of the received and managed pixelated functional map.
Optionally, the method comprises preprocessing the received functional map before the matching; the preprocessing comprises a member of a group consisting of: registering the received functional map according to at least one of the functional maps and denoising the received functional map.
More optionally, each the first and second medical information comprises a member of a group consisting of: a laboratory result, a therapeutic procedure record, a clinical evaluation, an age, a gender, a medical condition, identification information, genetic information, a patient medical record, a metabolism data, blood pressure, a sensitivity, an allergy, a population relevance, an epidemiologic classification, a patient history, and a treatment method.
Optionally, each the received and managed functional map comprises a member of a group consisting of: a positron emission tomography (PET), a PET—computerized tomography (CT), a single photon emission computed tomography
(SPECT), an extracorporeal gamma scan, an extracorporeal beta scan, an intracorporeal gamma scan, and an intracorporeal beta scan.
Optionally, each the first and second plurality of biological activity indications comprises an uptake level of radiation emitted from a plurality of tracers.
Optionally, managing the plurality of functional maps comprises at least one prototype of a pathological biological activity.
Optionally, at least one of the managed functional map is associated a pathological diagnosis, the diagnosis of the received functional map being determined according to the pathological diagnosis of members of the matching set.
Optionally, the managing comprises managing more than 1,000,000 functional maps.
Optionally, the matching comprises matching topological similarities between the received functional map and at least one of the plurality of managed functional maps.
Optionally, the matching comprises matching common radiation emission pattern between the received functional map and at least one of the plurality of managed functional maps.
Optionally, the received functional map and at least one of the plurality of managed functional maps are kinetic functional maps.
Optionally, at least one of the plurality of managed functional maps is associated with a method of treatment and with a success evaluation thereof, the using comprises outputting a treatment recommendation according to respective the evaluation of at least one member of the matching set.
Optionally, the method further identify a plurality of biological pathways in the received and managed functional maps respectively according to the first and second plurality of biological activity indications, the matching comprises matching the plurality of biological pathways.
Optionally, the using comprises classifying the functional map.
Optionally, the using is performed in real time.
According to one aspect of the present invention there is provided a system for analyzing a functional map of at least one tissue of a current patient. The system comprises an input unit configured for receiving the functional map being associated with a plurality of first biological activity indications and a database configured for storing a plurality of functional maps, each being associated with a plurality of second biological activity indications. The system further comprises an analyzing unit for identifying a matching set of the stored functional maps by matching between the plurality of first and second biological activity indications. The matching set is used for a member of a group consisting of: an image data acquisition and treatment.
Optionally, the system further comprises an integration module configured for preprocessing the functional map, the preprocessing comprises a member of a group comprises: registering the functional map according to at least one of the stored plurality of functional maps and converting the functional map to a data format of at least one of the stored plurality of functional maps.
Optionally, the system further comprises a display unit configured for displaying the matching set.
Optionally, the analyzing unit is configured for weighing member of the matching set according to their potential relevance to the received functional map.
According to one aspect of the present invention there is provided a distributed system for analyzing a functional map of at least one tissue of a current patient. The system comprises a plurality of client terminals each configured for receiving the functional map being associated with a plurality of first biological activity indications, a database configured for storing a plurality of functional maps, each being associated with a plurality of second biological activity indications, and an analyzing unit for matching between the plurality of first and second biological activity indications. The matching is used for a member of a group consisting of: an image data acquisition, a diagnosis of the received functional map, a classification of the received functional map.
According to one aspect of the present invention there is provided a research tool for identifying a trial group. The research tool comprises an input unit configured for receiving a set of characteristics defining a patient profile, a database configured for storing a plurality patient profiles, an analyzing unit for identifying a trial group by matching between the set of characteristics and the plurality patient profiles, and an output unit for outputting the trial group.
Optionally, each the patient profile being associated with a functional image.
Optionally, the trial group is a control group.
Optionally, the set of characteristics comprises at least one first biological activity, at least one of the plurality patient profiles comprises at least one second biological activity analyzing unit for identifying a trial group by matching between the at least one first biological activity and the at least one second biological activity.
According to one aspect of the present invention there is provided an imaging system for capturing a functional image of at least one tissue of a patient. The imaging system comprises at least one detector for obtaining a source functional image being associated with at least one first biological activity indication, a database configured for storing a plurality of reference functional images each being associated with at least one second biological activity indication, and an analyzing unit for matching between the at least one first and second biological activity indications. The analyzing unit is configured for controlling the at least one detector according to the matching.
Optionally, the functional image depicts a segment of a requested area, the controlling comprises maneuvering the at least one detector to capture an additional segment of the requested area according to the matching.
Optionally, the detector comprises a radiation transmitting unit for emitting radiation toward the segment; the controlling comprises adjusting the intensity of the emitted radiation according to the matching.
Optionally, the detector is configured for obtaining the functional image, by a first modality, selected from the group consisting of a single photon emission computed tomography (SPECT) unit, a positron emission tomography (PET) unit, an extracorporeal, hand-held gamma scan unit, an extracorporeal unit, hand-held beta scan, an intracorporeal gamma scan, an intracorporeal beta scan, an intravascular gamma scan, and an intravascular beta scan.
Optionally, the source functional image is a preliminary image mapping a radiation emitted from a first tracer; the controlling comprises outputting a recommendation for the injection of a second tracer based on the matching.
According to one aspect of the present invention there is provided a method for obtaining a functional image of at least one tissue of a patient. The method comprises a) receiving a preliminary functional image associated with at least one first biological activity indication, b) matching between the at least one first biological activity and a plurality of respective biological activities each of a reference functional image, and c) outputting a instructions for obtaining an additional preliminary functional image according to the matching.
Optionally, the method further comprises d) obtaining the additional preliminary functional image according to the instructions and e) combining the preliminary functional images producing a final functional image.
Optionally, the method further comprises repeating b)-e), the at least one first biological activity are taken from the final functional image.
Optionally, the instructions comprises a member of a group comprises: an identifier defining which tracer to use during the obtaining, an identifier defining in which concentration to use a tracer during the obtaining, a point of view of at least one detector which is used for the obtaining, a region of interest to be imaged during the obtaining, and refining the preliminary functional image.
According to one aspect of the present invention there is provided a method for calculating a treatment recommendation. The method comprises a) managing a plurality of patient profiles each being associated with a plurality of patient medical records, at least one treatment, and an outcome evaluation of the at least one treatment, b) receiving a current patient profile being associated with a plurality of related medical records, c) identifying a matching set of the managed patient profiles by matching between the plurality of patient and related medical records, and d) calculating a medical recommendation according to the at least one treatment of members of the matching set.
Optionally, the plurality of patient profiles includes the at least 1,000,000 patient profiles.
Optionally, each the patient profile having a functional map, each the functional map being associated with a plurality of biological activity indications, the identifying comprises identifying the matching set by matching between biological activity indications of the current patient profile and the plurality of patient profiles.
Optionally, each the plurality of patient medical records comprises a member of a group consisting of: a laboratory result, a therapeutic procedure record, a clinical evaluation, an age, a gender, a medical condition, identification information, genetic information, a patient medical record, a metabolism data, blood pressure, a sensitivity, an allergy, a population relevance, an epidemiologic classification, a patient history, and a treatment method.
Optionally, at least some of the plurality of patient medical records are associated with a time tag indicating a related occurrence or examination time.
Optionally, each the at least one treatment is associated with a reliability score, the calculating comprises calculating the medical recommendation according to the reliability score of members of the matching set.
Optionally, each the patient profile is associated with a current treatment record, the identifying comprises identifying the matching set by matching between current treatment records of the current patient profile and of the plurality of patient profiles, and the medical recommendation comprises a continuation treatment for the current patient profile.
More optionally, the current treatment record profile is associated with a respective outcome evaluation.
Optionally, the method further comprises e) updating the current treatment record of the current patient profile with the medical recommendation and the respective outcome evaluation with an outcome of a respective treatment and f) repeating a)-d) the current treatment record is the updated current patient profile and the respective outcome evaluation is the outcome of a respective treatment.
Optionally, the medical recommendation is a medical recommendation of a phase in an ongoing treatment and the outcome is a current outcome of the phase, the updating and repeating are performed during the ongoing treatment.
Optionally, the medical recommendation comprises a request for an additional evolution. The method further comprises e) updating at least one of the plurality of patient medical records with the additional evolution and f) repeating a)-d) the current patient profile being updated with the additional evolution.
Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.
Implementation of the method and/or system of embodiments of the invention can involve performing or completing selected tasks manually, automatically, or a combination thereof. Moreover, according to actual instrumentation and equipment of embodiments of the method and/or system of the invention, several selected tasks could be implemented by hardware, by software or by firmware or by a combination thereof using an operating system.
For example, hardware for performing selected tasks according to embodiments of the invention could be implemented as a chip or a circuit. As software, selected tasks according to embodiments of the invention could be implemented as a plurality of software instructions being executed by a computer using any suitable operating system. In an exemplary embodiment of the invention, one or more tasks according to exemplary embodiments of method and/or system as described herein are performed by a data processor, such as a computing platform for executing a plurality of instructions. Optionally, the data processor includes a volatile memory for storing instructions and/or data and/or a non-volatile storage, for example, a magnetic hard disk and/or removable media, for storing instructions and/or data.
Optionally, a network connection is provided as well. A display and/or a user input device such as a keyboard or mouse are optionally provided as well.
Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.
In the drawings:
Exemplary embodiments of the present invention describe methods and systems for calculating a treatment recommendation. These embodiments are based on a plurality of reference patient profiles; each includes a plurality of patient medical records, at least one given treatment, and an outcome evaluation of the given treatment. A current patient profile, which is associated with a plurality of related medical records, is received and matched with the reference patient profiles. The match allows the identification of a matching set that includes members with patient medical records that have a certain potential relevance to the patient medical records of the current patient profile. Each record of the matching set specifies a certain given treatment and the outcome thereof The matching set allows the calculation of a medical recommendation according to given the treatments which are specified in the matching set. For example, the medical recommendation may be based on the identification of a treatment that has a positive outcome evaluation, the most prevalent positive outcome evaluation, or a combination of the level of success of the possible outcome evaluations and/or the prevalence of the possible outcome evaluations.
Exemplary embodiments of the present invention describe methods and systems for analyzing, optionally in real time, patient data, such as a functional map, functional image, such as PET and SPECT images, and/or patient profile, of a patient using a reference database that contain a plurality of reference functional images, functional maps, and/or patient profiles. These embodiments allow, inter alia, identifying a matching set of functional images, maps, and/or patient profiles from the reference database by matching between the patient data and records of a reference database. Such a matching set can be used for identifying, classifying, and/or diagnosing pathological indications, which are depicted in the functional image, and for alarming and/or notifying the physician about such pathological indications.
Optionally, the matching set is used for refining the process of acquiring the functional image.
Optionally, the reference database is used for managing a plurality of patient profiles. Each patient profile comprises one or more functional images, each as defined above and medical information that is related to the patients which are imaged in the one or more of the functional images.
Optionally, the system is used for locally refining the received functional image. The received functional image may depict a segment of a certain requested area, a preliminary image that depicts partial emissions of one or more tracers, and/or an incomplete imaging of a certain area. In such an embodiment, each matching set may be used for generating instructions to an imaging system, thereby allowing an active vision, optionally as described below.
Optionally, this refinement allows reducing the number of detectors which are needed for capturing the functional image, reducing the computational complexity which is needed for reconstructing the received functional image and/or for reducing the amount and/or medicaments concentration which are injected to the patient. Exemplary embodiments of the present invention are a research tool generates trials groups, such as control groups, for experiments, using a using a reference database that comprises a plurality of functional images and/or patient profiles.
Some exemplary embodiments of the present invention describe a method that includes managing a plurality of pixelated functional maps, each map or a pixel element thereof is associated with a plurality of biological activity indications, such as values that represent the emission of one or more tracers, for example radionuclide sodium-24 tracers, from one or more tissues. When a pixelated functional map of a patient that is associated with a plurality of such biological activity indications is received, the managing allows the identification of a matching set that includes functional images that record respective biological activity indications. The matching set is used for image data acquisition, diagnosing the received functional map, refining the received functional map, operating the imaging system that created the functional image, and/or for classifying the received functional map.
Optionally, as a high computational complexity may be needed in order to match between the new functional map and the stored functional maps, a hardware architecture that allows heavy processing may be used, optionally as described below. Such architecture can be used to reduce the processing time of the matching and/or analysis process.
Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.
Reference is now made to
In some embedment of the present invention, the matching system 100 is used as a CAD system that assist physicians, such as radiologists, in diagnosing pathological, traumatic, or healthy indications in the source image 104. The matching system 100 assists physicians by leveraging the reference images 105 and additional dimensions which are associated therewith, optionally as described below, to identify relevant medical cases and their courses/acquisition, methods, treatments, and the like. In such an embodiment, the matching system 100 may assist physicians to identify cancerous, juxta cancerous, wounded, and normal tissues.
Optionally, the matching system 100 is used for automatic diagnosis of the patient. Optionally, the matching system 100 is used for alerting a patient, a physician, and/or a central server that is used for monitoring patients about a certain biological activity and/or inactivity in the patient body. The system may also be used as a research tool that allows a researcher to define a control group or a test group, as further described below.
Reference is now also made to
As described above and shown at 201, the reference patient database 102 manages a plurality of reference images each associated with a plurality of biological activity indications. Then, as shown at 202, a source image that includes a pixelated functional map is received. The source image is associated with a plurality of biological activity indications, as further described below. The input unit 101, which may be installed on a terminal, such as a personal computer or a server, is designed to receive the source image 104 either directly from a medical imaging system or indirectly via a content source. A medical imaging system comprises imaging by a modality, such as a PET, a PET-CT, a single photon emission computed tomography (SPECT), an extracorporeal gamma scan, an extracorporeal beta scan, an intracorporeal gamma scan, an intracorporeal beta scan, and output of a camera, such as disclosed in U.S. patent application Ser. No. 11/607,075, filed Dec. 1, 2006; U.S. patent application Ser. No. 11/034,007, filed Jan. 13, 2005; U.S. patent application Ser. No. 09/641,973, filed Aug. 21, 2000; PCT Patent Application No. PCT/IL2006/000562, filed May 11, 2006; PCT Patent Application No. PCT/IL2006/001291, filed on Nov. 9, 2006; PCT Patent Application No. PCT/IL2006/000840, filed Jul. 19, 2006; PCT Patent Application No. PCT/IL2006/000834, filed Jul. 19, 2006; PCT Patent Application No. PCT/IL2006/000059, filed Jan. 15, 2006; PCT Patent Application No. PCT/IL2005/001215, filed Nov. 16, 2005; PCT Patent Application No. PCT/IL2005/001173, filed Nov. 9, 2005; PCT Patent Application No. PCT/IL2005/000575, filed Jun. 1, 2005; PCT Patent Application No. PCT/IL2005/000572, filed Jun. 1, 2005; PCT Patent Application No. PCT/IL2005/000048, filed Jan. 13, 2005; and PCT Patent Application No. PCT/IL03/00917, filed Nov. 4, 2003; Israel Patent Application No. 172349, filed Nov. 27, 2005; and Israel Patent Application No. 171346, filed Oct. 10, 2005. The contents of all of the above documents are incorporated by reference as if fully set forth herein. A content source may be a PACS server, a PACS workstation, a computer network, or a portable memory device such as a DVD, a CD, a memory card, etc. The content source hosts and optionally allows the access to various multidimensional patient profiles, or dimensions thereof.
Optionally, the source image 104 comprises two or more functional images depicting the same tissues in the patient's body. The reference patient database 102 comprises references images each comprises two or more functional images depicting respective tissues in a body of another patient. Optionally, the functional images 104, 105 are pixelated. The functional images are optionally produced by radioactive emission. A functional image may be based on radiation emitted from radioactive tracers, such as gamma-emitting radiopharmaceuticals, which are injected into the body of the patient. The uptake of tracers is different between different tissues and between healthy, defective, and tumor tissues. Such an uptake, which is reflected by the radiation emitted from each tissue, is used for evaluating a biological activity, such as a metabolic activity of body tissue. For example, a functional image may image cardiac rhythm or respiratory rhythm, tissue metabolism, blood flow, evaluation of coronary artery disease, receptor binding, brain perfusion, and liver activity. Other indications of biological activities or inactivities that may also be depicted in a functional image may be based on the uptake rate of tracers in the related one or more tissues of the patient. Since the uptake rate of tracers is different between a healthy tissue and a tumor and is furthermore different between malignant and benign portions of a tumor, functional images or maps are of importance in tumor localization and volume determination, and especially, localization and volume determination of malignant portions of tumors.
Optionally, the functional image is a 3D medical image or a sequence of 3D medical images, such as a sequence of PET-CT, SPECT, and/or Gamma scan images that comprises a plurality of voxels. In such an embodiment, the one or more functional images provide information about a plurality of biological activities in each voxel of the source image 104. For example, each voxel may be associated with the uptake rate of a number of different tracers, such as iron isotopes, In-111 chloride, and Tc-99m labeled colloids (7-10). This use of multi-dimensional data, covering domains such as spatial/organs, variety of tracers, and time variation, allows obtaining properties of the underlying biological processes and conclusions related to the clinical condition. Furthermore, even if a radiation, which is emitted from a certain isotope, has an imperfect specificity, the combination of its radiation with radiations of other isotopes may have a specificity that allows the agent that receives the outputs of the matching system to diagnose the pathology of the imaged tissues in the received source image.
Optionally, the biological activity or inactivity is documented as a value representing the interception of rays, such as gamma rays, which are emitted indirectly from the respective area, optionally by a positron-emitting radioisotope, which is introduced into the body on a metabolically active molecule.
Each one of the source images is optionally associated with medical information that is related to the patient. In such an embodiment, for each of some or all of the reference images 105 is associated with related medical information of a patient that her organs are depicted in the related reference image 105. As used herein, medical information means, inter alia, information which is related to the patient, such as laboratory results, therapeutic procedure records, clinical evaluations, age, gender, medical condition, ID, genetic information, patient medical record, data indicating of metabolism, blood pressure, patient history, sensitivities, allergies, different population records, treatment methods and the outcome thereof, epidemiologic classification, and patient history, such as treatment history. Optionally, each one of the source and reference images 104, 105 is optionally associated with previous and/or current structural and/or functional images of respective one or more tissues. Optionally each one of the previous images is associated with information that indicates a diagnosis thereof, a list of pathological and/or biological indications, and selected treatments and/or medicaments. Other important features, such as 3D affine transformation descriptors may also be associated with the source image. The input unit 101 is optionally adapted to interface with more than one content source.
Optionally, the input unit 101 preprocesses the source image 104 before it is forwarded to the analysis unit 103 and/or stored in the reference patient database 102. Preferably, the source image 104 comprises a pixelated functional image that is preprocessed according to the requirements of the analysis unit 103. In one embodiment of the present invention, the pixelated functional image is denoised and/or enhanced using commonly known edge preserving filters before it is forwarded and optionally stored.
As described above, the source image 104 may be associated, or allowing the matching system 100 to associated it, with medical information of a related patient. In such an embodiment, each one of the pixelated functional images, which are hosted in the reference patient database 102, is also associated with related medical information. The reference patient database 102 may also store a number of prototypes of pathological biologic activities and/or indications, for example a pixelated medical map of one or more tissues that depicts an emission of an accumulation of radioactive glucose fluorodeoxyglucose (FDG) in an exemplary cancerous tissue.
For brevity, one or more of the reference images 105 and/or medical information, which are related to a certain patient and/or a certain patient prototype are referred to as a multidimensional patient profile. In such an embodiment, each dimension of the multidimensional patient profile provides information about a biological activity and/or indication in one or more voxels of a functional image or optionally medical information that is related to the patient that one or more of her organs are depicted in the functional image. For example, a dimension may be a functional image that images an emission of a tracer from a biological activity of one or more tissues.
Optionally, the multidimensional patient profile 104, 105 includes a pathologic classification, a clinical stage, and optionally a prognosis of such a pathologic classification. Optionally, one or more of the multidimensional patient profiles 104, 105 are associated with one or more therapies. Each therapy is associated with a related success rate value.
Optionally, the pathologic classification or other diagnosis and/or classification that is associated with the multidimensional patient profile 104, 105 and/or included therein is tagged with a reliability score that reflects the skills of the agent that provided it, the reliability of the organization which is associated with the agent, and/or the reliability of the study from which the data is taken. As used herein an agent means a physician, a measurement device, a measurement system, an imaging device, an imaging system, and an organization means a laboratory, a hospital, a medical service, an association of hospitals and/or laboratories, a geographic location of hospitals and/or laboratories, a manufacture of an agent and/or the training center that trained the agent.
Optionally, the reference patient database 102 hosts a plurality of respective functional images. In such an embodiment, each voxel of each reference image 105 is associated with a plurality of related biological activities. In such a manner, the analysis unit 103 may match between each voxel of the source image 104 and voxels of one or more of the reference images 105, which are optionally respective thereto. In an exemplary embodiment of the invention, the reference patient database 102 hosts more than a 5,000 of functional images each, of an actual patient or a known and explicit profile. Optionally, each functional image is stored along with medical information, optionally as described above, and may be referred to as a multidimensional patient profile. Each dimension in the multidimensional patient profile is the biological activity in one or more voxels of the functional image or a medical information datum.
Optionally, the multidimensional patient profile includes a respective structural image, which is optionally registered with one or more of the related functional images. The structural image is produced by reflections of penetrating rays from the internal tissues of the respective organs of the patient. Such a structural image may be produced, for example, by x-ray, CT, ultrasound, and MRI scans, which provide structural map of the internal tissues of the patient.
Optionally, the number of multidimensional patient profiles 105, which are stored in the reference patient database 102, is greater than 5,000, 50,000, 500,000, 1,000,000, 10,000,000, 100,000,000, 1,000,000,000, or intermediate values. The size of the database may be affected by the standard deviation of the records and the variance of the records. Optionally, the number of different patients whose has a multidimensional patient profile in the reference patient database 102 may be of a similar magnitude. Optionally, 5, 10, 100, 1000 or more separately identifiable functional images are provided per multidimensional patient profile in the reference patient database 102. The number of dimensions analyzed in each multidimensional patient profile may be, for example, 5, 10, 20, 40, 100, 1000, or greater or intermediate values.
The reference patient database 102 is optionally distributed in a number of servers or other hosting computing units, for example 10, 50, 100, 1000, or intermediate or greater numbers of hosting computing units. The connections between these servers are optionally secured in order to maintain data safely and privacy. Optionally, the technical specification of the system varies according to the resolution of the functional images, the number of records in the reference patient database, and the number and/or distribution of the input units 101. For example, larger images and multidimensional patient profile with more dimensions may need more bandwidth, calculating power, and storage. Optionally, in order to increase the robustness if the reference patient database, each record is stored more than once, optionally in a number of different servers which are optionally distributed in different geographical locations. Clearly, by maintaining a number of copies, the degree of data security increases and the latency of storing and retrieving the data decreases.
As described above, the source image may be received with respective medical information. This combination may be referred to as a new multidimensional patient profile. Optionally, the new multidimensional patient profile is stored for future use. Optionally, the input system comprises an integration module for integrating different modalities, such as functional and structural images from different imaging systems, for example, MRI systems, CT systems, Ultrasound (US) systems, and X-ray based systems that contain multiple dimensions and/or markers. Optionally, the integration module is designed for converting data format in an automated and/or semi-automated manner. The conversation allows the analysis unit 103 to handle data from various data sources. Optionally, the integration module is designed for registering the source image according to predefined model that has been used for registering the respective reference images. Such a registration can substantially reduce the computational complexity of the matching process.
The analysis unit 103 is designed to match between the source image 104, or the new multidimensional patient profile 104, and a plurality of respective reference images 105, or a plurality of multidimensional patient profiles 105, which are stored in the reference patient database 102. As shown at 203, after the source image is received at the analysis unit 103, a matching set of the reference images is identified by matching between the plurality of the first and second biological activity indications. The matching allows identifying a set of the hosted multidimensional patient profiles 105 that a plurality of common biological activities and/or pathogenic indications with the new multidimensional patient profile 104.
Optionally, the analysis unit 103 gives each member of the matching set a potential relevance value that is determined according to the potential relevance thereof to the new functional image and/or to the new multidimensional patient profile 104. Optionally, the potential relevance value is determined according to the proximity of the parameters that represent common biological activity indications in the members of the matching set.
The matching between the source and the reference images may be based on topological similarities between the source image and the reference images. Such a matching allows the agent to identify a matching set of multidimensional patient profiles that includes a number of common biological activities and/or indications with the patient that is depicted in the source image. The aforementioned matching allows the detection of a matching set that have a common radiation emission pattern with the source image. For example, in functional imaging of one or more brain activities, it is possible to match between emission patterns that may account as normal or abnormal functional properties of one or more regions, normal or abnormal dependencies between the one or more regions, and pathologies associated with malfunctions of biological pathways in the one or more regions. Matching such an image emission pattern may be used for classifying the new multidimensional patient profile.
In some embodiments of the present invention, the source and the reference images are optionally registered and matched according to known registration and matching methods and process. For example, see A. Venot, et al. Automated Correction of Patient Motion and Gray Values Prior to Subtraction in Digitized Angiography, IEEE Transactions on Medical Imaging, vol. MI-3, no. 4, 1984, pp 179-186; G. Malandain et al., Matching of 3D Medical Images with a Potential Based Method, IRIA, no. 1890, 1993, pp 1-37; L. R. Schad, et al., Three Dimensional Image Correlation of CT, MR, and PET Studies in Radiotherapy Treatment Planning of Brain Tumors, Journal of Computer Assisted Tomography, vol. 11, no. 6, 1987, pp 948-954; B. L. Holman, R. E. Zimmerman, et al., Computer-Assisted Superimposition of Magnetic Resonance and High-Resolution Technetium-99m-HMPAO and Thallium-201 SPECT Images of the Brain, The Journal of Nuclear Medicine, vol. 32, no. 8, 1991, pp 1478-1484; B. A. Birnbaum et al. Diagnosis with Fusion of MR, CT, and Tc-99m-labeled Red Blood Cell SPECT Images, Radiology, vol. 181, no. 2, 1991, pp 469-474, which are incorporated herein by reference.
Optionally, the new multidimensional patient profile 104 and the plurality of multidimensional patient profiles 105 include an electrophysiological reading that measures an electrical activity of one or more tissues of the related patient along a period. Optionally, the electrophysiological reading includes one or more electrophysiological readings, such as electrocardiography reading, electroencephalography reading, electrocorticography reading, electromyography reading, electrooculography reading, electroretinography reading, and electroantennography reading.
Optionally, the matching between the new multidimensional patient profile 104 and the plurality of multidimensional patient profiles 105 may include an additional or an alternative phase of matching between electrophysiological readings. Such a matching allows the user to identify a matching set that includes multidimensional patient profiles that have electrophysiological readings, which are substantially similar to the electrophysiological readings of the probed patient.
It should be noted that an arrhythmia, such as atrial fibrillation, one or more ectopic regions in the heart, an ischemia, changes in existence of biochemical channels which are part of the electrical conduction system, for example connexin-42, and/or changes in the activity and/or concentration of intracellular and intercellular calcium handling proteins, usually have a known electrocardiography reading pattern.
The aforementioned matching allows the detection of a matching set of multidimensional patient profiles that have a common electrophysiological reading with the new multidimensional patient profile. Such a common electrophysiological reading may be used for classifying and/or diagnosing the new multidimensional patient profile and/or alarming the user of the matching system 100 about a possible detection of one or more pathologies which have been identified in members of the matching set.
In one embodiment of the present invention, the source and at least some of the reference images are four-dimensional (4D) medical images of an organ, such as the heart. A 4D medical image is a data set composed of a time-series of 3D medical images that reflects the behavior of the depicted tissue during a certain period. In such an embodiment, the reference and the source images, which may also be known as kinetic images, may be correlated before they are matched by the analysis unit 103. Matching a 4D medical image may be important in organs such as the heart wherein the shape of the organ substantially change over time and can provide information about the pathological level thereof.
In such an embodiment, the matching that is performed by the analysis unit 103 may be performed with respect to the time domain. Such systems, methods, and associated tools may be applied to cardiology, oncology and brain imaging with novel imaging systems, including for example with the nuclear imaging technology presented by Spectrum Dynamics in International Application No. WO2006/051531 published on 18 May 2006 that is incorporated herein by reference.
As described above, each one of the multidimensional patient profiles 104, 105 may comprise medical information, such as medical history, about a related patient. Such information, as described above, may comprise personal information about the patient, such as his or her age, gender, and physical condition at the time the scan has been held. As the differences between biological indications of patients with different medical condition and/or history are substantial, such information may be important, in some embodiments, in order to output efficient recommendation, treatment guidelines, or matching set that can be used by the physician, optionally as described below. For example, it is clear that low red and/or white blood cell count has different meaning if the patient is treated with chemotherapy for cancer or not.
Optionally, an initial diagnosis, which is performed by an agent or attached to the new patient profile, is also included. Such medical information may also be used as another dimension in the multidimensional patient profile 104 for the analysis of the source image, as described below.
Optionally, the matching that is performed by the analysis unit 103 is based on processing the data in the multidimensional patient profiles 104, 105. Optionally, the analysis unit 103 processes the data in order to detect interactions and/or complex biological processes that may last for a certain period. For example, the analysis unit 103 may correlate between a timeline that describes the variability of one or more biological and/or pathological indications in the new patient profile and a respective timeline in the multidimensional patient profile which are hosted in the reference patient database.
Optionally, the measuring includes applying one or more of a variety of statistical and network analysis techniques to one or more dimensions of the multidimensional patient profile. Such an analysis may include an analysis of gene expression, proteomics, transcriptomics, gene regulatory network, metabolic pathways, and/or cellular signaling. For example, the analysis unit 103 may measure an absolute concentration of proteins and/or messenger ribonucleic acid (RNA) of a specific type and a specific state, such as phosphorylated mRNA, glycated mRNA, and various protein conformations. The detected and/or measured data is matched with respective interaction and/or measurements in the multidimensional patient profiles 105 of the reference patient database 102.
In such an embodiment, a multidimensional patient profile includes sequential data of biological activities that is optionally based on dynamic and/or static properties of one or more tracers. The biological activities may have time dependency among them. For example, an uptake of one tracer that is followed by an uptake of a subsequent uptake of another tracer may be indicative to the existence of a time-dependency between two biological activities and potentially to the understanding that one biological activity is the cause and/or a part of the cause of another biological activity and may be associated with a certain pathological indication of the patient. Optionally, the data in the reference patient database 102 is arranged in data tables, which support the aforementioned measurements and interactions.
Optionally, the reference patient database 102 hosts at least 5,000 multidimensional patient profiles. Each one of the multidimensional patient profiles comprises information about the patient from various evaluation and imaging systems and agents, such as one, two, three, four or more of epidemiologic, genetic, functional, chemical, and treatment related information. Matching the new multidimensional patient profile 104 with the multidimensional patient profiles 105 may yield one or more matching sets. Each member of a certain matching set has a combination of biological activities and/or indications that is common to all the members of the certain matching set. The relation between the biological activities and/or indications in this combination may not be obvious to the common physician or even known from the medical literature. Thus, the matching system 100 that optionally automatically match between the new multidimensional patient profiles 104 and the multidimensional patient profiles 105 can detect combinations that include relations between various biological activities which are not obvious or known to the agent that diagnoses the patients with the new multidimensional patient profiles 104.
As the matching is performed with a large scale of multidimensional patient profiles, fuzzy logic methods may be used for identifying the matching set. As commonly, known fuzzy logic is derived from fuzzy set theory dealing with reasoning that is approximate rather than precisely deduced from classical predicate logic, see Klir, George J.; St Clair, Ute H.; Yuan, Bo (1997). Fuzzy set theory: foundations and applications. Englewood Cliffs, N.J.: Prentice Hall. ISBN 0133410587 and Klir, George J.; Yuan, Bo (1995). Fuzzy sets and fuzzy logic: theory and applications. Upper Saddle River, N.J.: Prentice Hall PTR. ISBN 0-13-101171-5, which are incorporated herein by reference.
As described above and shown at 204, after the source image is received at the analysis unit 103, a matching set of the reference images is identified by matching between the plurality of the first and second biological activity indications. Optionally, the matching is performed between predefined ranges which are set around the values given at the multidimensional patient profile 104. As described above, the multidimensional patient profile 104 comprises different values that represent medical information and biological indications which are related the patient. In such an embodiment, as the matching is between predefined ranges and not according to discrete values the intersecting group may include profiles of patients which are not exactly as the profile of the current patient.
Optionally, the matching of each one of the values and/or the ranges of the patient profile is weighted according to an estimation that reflects the importance. For example, a potential relevance between biological indications such as hemoglobin, hematocrit, and/or iron level measurements may receive a higher weight than the weight that is given to the height or the gender of the patient.
Optionally, a weight is given to a ratio or any other function that is based on a number of values and/or the ranges of the patient profile. For example, the ratio of hemoglobin weight to hematocrit is given with a high weight. Such a ratio distinguishes the normally colored cells from paler cells to classify different anemias and aid in determining cause.
Optionally, the weights are dynamic and depend on other values such as the treatment that is given to the patient, the age of the patient, his medical history, and/or his medical condition.
As shown at 204, after the matching set has been identified it is used for image data acquisition, diagnosis of the source image, calculation of treatment guidelines, and/or classification of the source image. The matching set may comprise multidimensional patient profiles of patients with similar biological activities and/or indications that receive successful treatments and with multidimensional patient profiles of patients with similar biological activities and/or indications that receive unsuccessful treatments. Such matching sets may be useful for allowing the physician to select one or more method of treatments, to optimize and/or to reduce the radiation doses to which the patient is exposed, and to optimize and/or to reduce a medicament dose that the patient receives.
Optionally, a reference patient database 102 with more dimensions allows the matching of more combinations of different dimensions and/or interactions between different biological activities. Such a matching may be used for detecting combinations and interactions, which are not intuitive or based on the known studies and/or tests. Such a multidimensional data analysis may be performed using differential equations and/or control theory methods, as applicable to dynamic systems such as a biological entity, for example the human body.
As described above, the matching system 100 is designed to receive a source image and optionally medical information from an imaging system and/or a storage system and to match it with the reference images and/or other records of the reference patient database 102. As the functional image is optionally matched with large scale of multidimensional patient profiles and optionally processed and analyzed for the identification of complex biological processes that may last for a certain period, the quality of thereof may be relatively low, for example a functional image with high levels of noise. Optionally, the matching system 100 allows using imaging cameras with a relatively low number of detectors, such as a hand-held imaging camera that is designed for capturing images during a data-responsive scanning, to perform a real time reconstruction, and to determine in real time whether additional data is needed to achieve a match, as described above.
Optionally, the analysis unit 103 uses information that is found in the matching set to complete, to denoise, to calibrate, and/or to change areas in the received source image.
It should be noted that using such a matching system 100 may assist particularly in standardizing the analysis of functional images and generally in standardizing the analysis of multidimensional patient profiles. As commonly known, not all the physicians have a common set of guidelines for diagnosing a functional image or many other variants of a patient profile. For example, while a certain physician checks the hippocampus region for diagnosing early Alzheimer's dementia, another physician may check other regions of the brain, such as the medial temporal lobes and the anterior cingulate. In particular, such the matching system 100 may be used for assuring that certain biological activities and indications are probed whenever a functional image or any other variant of a patient profile is diagnosed and/or classified by a physician, such as a general radiologist.
Optionally, the reference patient database 102 is used by the analysis unit 103 for classifying pathological indications that have more than one visible and/or measurable characteristics and not a clear surrogate marker. Optionally, the reference patient database 102 may be used for detecting and/or anticipating the occurrence of a heart failure. Such a detection and/or an anticipation may by based on various biological activities which are documented in the multidimensional patient profiles, including but not limited to echocardiography, blood tests, cardiac mapping, which is optionally isotope based, anatomical information, for example from CT and/or angiography procedures, quality of life questionnaires, electrophysiology parameters, etc.
In one embodiment of the present invention, the matching system 100 is used for solving an inherent problem of the SPECT image analysis. A 3D imaging system, such as SPECT system, assesses a relative decrease in the uptake of a tracer in a certain region by comparing the uptake thereof with the uptake of other regions. The uptake is determined according to the rate of reduction in the emission flow. Such a comparison may be used for detecting regions with stenosis that is relatively high in relation to other regions. It is more difficult, and sometimes impossible, to detect milder stenosis in other regions of the functional image. As described above, the analysis unit 103 is designed for matching a SPECT image with other images. In such an embodiment, each region in the image is compared with respective regions in other SPECT images. In such a manner, the uptake of one region is matched against the uptake in a respective region and not against the uptake of other regions in the same image. Such a matching may provide pathological information that would have gone unnoticed in a commonly used diagnosis. It should be noted that a comparison, such as the aforementioned comparison, is between absolute values taken from respective regions and therefore provide a more accurate outcome than the commonly practiced comparison that is performed between relative values taken from different, unrelated regions.
Reference is now also made to
In such an embodiment, each one of the client terminals 101 may be used for adding a new patient profile 104 to the reference patient database 102 and/or for forwarding it to the analysis unit 103 for analysis, for example as further described above.
Optionally, the matching system 100 is connected to one or more user interfaces (UIs), which are optionally installed in one or more of the client terminals 101. Each UI allows one or more of the users to extract statistical information from the reference patient database 102. Such a UI may be used for producing improved understanding of the biological processes. Optionally, the UI allows the user to identify and to analyze biological pathways, cell processes, and cellular circuits based on the match between the new multidimensional patient profiles 104 and the multidimensional patient profiles 105.
Optionally, the UI is designed to display the output of the analysis unit 3. Optionally, the analysis unit 3 outputs a list of the matching multidimensional patient profiles. Optionally, the list is sorted according to the potential relevancepotential relevance values of the matching multidimensional patient profiles.
As described above, the new multidimensional patient profiles 104 may be matched with a matching set that comprises multidimensional patient profiles, which have been classified as having biological activities and/or indications of one or more pathological diagnosis. Optionally, the analysis unit 103 generates a complete tree of the one or more pathological diagnosis and/or one or more suggested treatments for each one of the pathological diagnosis and forward it for a display at the client terminal from which the new multidimensional patient profiles 104 have been received. Optionally, the tree is weighted according to the prevalence of a certain match and/or the prevalence of a certain diagnosis in the matched multidimensional patient profiles.
In such a manner, the physician receives a graphical display, such as a tree, optionally weighted, of possible diagnosis and suggested treatments. As described below, the suggested treatments may also be weighted, shown the physician the statistic of the treatment success.
As depicted in
Optionally, as described above, the matching system 100 is used as a research tool. Optionally, the UI allows a user to define search indicia with one or more and/or biological activities or expressions thereof. The UI instructs the analysis unit 103 to search for a match between the search indicia and the plurality of multidimensional patient profiles. Such a research tool 100 may be used for improving the understanding of the biological processes which are defined in the search indicia.
Optionally, the research tool 100 allows the user to define a genetic population, an environment, an age, a gender, a medical condition, etc. In such a manner, the user may define a test group for an experiment. Optionally, the research tool 100 allows users to upload data of test groups, which have been used in a certain experiment and/or study. In such a manner, an outcome of a future experiment, such as a sequential experiment, can be easily compared with the uploaded data of any test group. As the uploaded data is related to a number of different trials and studies, the analysis unit 103 may combine the results of several studies that address a set of related research hypotheses, generating a match, a classification, an alarm, or a diagnosis that is based on a meta-study, in which as many patients as possible participates.
As, in some embodiments of the invention, the reference patient database 102 is greater than 500,000, 1,000,000, 10,000,000, 100,000,000, 1,000,000,000, or intermediate values, numerous control and/or test groups may be defined for supporting specific combination of biological activities and/or medical information. For example, where A, B, and C denote different tracers, the matching system 100 may support a combination of an analysis with two tracers A+B, a combination with two tracers A+C, and a combination with two tracers B+C. As the number of potential tracers expands, more combinations may be possible and the number of documented pathologies increases. It should be noted that such an embodiment may be used for reducing the radiation to which a patient is exposed during a diagnosis process. The analysis may allow a physician to diagnose a biological activity based on a match with multidimensional patient profiles that has the same combination of tracers as the new multidimensional patient profile, and not based on the injection and the imaging of one or more additional tracers.
Optionally, the matched matching set is used by the physician to determine which additional examination is needed. As described above, the matching set includes patient profiles that have one or more characteristics, such as biological indications and/or medical information, in common with the profile of the patient. A segmentation of the matching set's members according to characteristics thereof, which are not in common with the characteristics of the new patient profile, can indicate which additional data is needed in order to evaluate more accurately which treatment should be given to the new patient. For example, if one segment of the matching set includes patent profiles of members with an indication of normal hemoglobin and non-pathologic diagnosis and another segment of the matching set includes patent profiles of members with an indication of low hemoglobin and a pathologic diagnosis the physician receive an indication that an hemoglobin level test is needed in order to diagnose the new patient more accurately.
Optionally, the matching system 100 is used as an adaptive system for instructing an agent during a medical operation. In such an embodiment, the agent constantly updates and/or reenters the new patient profile that is matched by the matching system 100. The matching system 100 reanalyzes the updated new patient profile and provides the physician with a new, optionally more accurate, matching set and/or treatment recommendation. In such a manner, a physician may use the matching system 100 to predict the outcome of possible outcomes of different operational actions during a medical operation.
It should be noted that matching the new multidimensional patient profile 104 with records of a database that hosts thousands of multidimensional patient profiles can substantially reduce the standard deviation of the matching set. The more multidimensional patient profiles are stored in the database the more the members of the matching set have in common with the new multidimensional patient profile 104. The reference patient database 102 comprises data that describes and/or depicts pathological biological activities and/or indications optionally in association with medical information. These records allow identifying a matching set that has members having one or more common characteristics with the new multidimensional patient profile 104. Such one or more common characteristics may not be clear or known from the known studies and/or tests. The matching is done between absolute values and based on real data that is taken from real patients and not based on processed models that usually cannot accurately reflect dynamic statistical data that is optionally constantly changed and updated with new records.
For example, the reference patient database 102 is uploaded with data collected from trials that has been performed by imaging simultaneously or sequentially a large variety of tracers, which may be referred to as a cocktail, trials that has been performed on different populations, and trials that has been performed on patients with medical information. Such data may be collected either from various studies or during the ordinary course of practicing medicine.
In such a manner, the accuracy of the matching substantially increases. If, for example, an uptake of a tracer is an indication of a certain biological activity has a specificity of ˜10%, the matching of the uptake of more tracers can provide a higher specificity of ˜1%.
Optionally, the reference patient database 102 is connected to other medical databases and can match between the multidimensional patient profiles and records from the other medical databases. Optionally, a multidimensional patient profile may be based on data from other medical databases.
In an exemplary embodiment of the invention, a system is provided to store and analyze all such data. It should be noted that such an uploaded data may be used for analysis, classification, alarming, and/or diagnosing, optionally as described above, and not only for research.
Optionally, the multidimensional patient profiles comprise a status record that describes the health of the related patient. If the patient has been diagnosed by the matching system 100 and/or by a physician as unhealthy patient, the status record may define an impairment of health or a condition of abnormal functioning of the patient or of one or more of the patient tissues. The multidimensional patient profiles comprise a record that describes and/or defines the treatment the patient received and a value, such as a weigh value, that defines the effectiveness of that treatment. Optionally, the analysis unit 103 is designed to suggest a therapy to the patient with is documented in the new multidimensional patient profile. In such an embodiment, the analysis unit 103 identifies a matching set of members having one or more dimensions in common with the new multidimensional patient profile. The dimensions may be medical information and/or a topological potential relevance between related functional images, optionally as described above: Optionally, the analysis unit 103 identifies which therapy has been used most successfully for recovering the members matching set, optionally using the aforementioned weight, and output a therapy suggestion or a list of weighted therapy suggestions based thereupon. Optionally, the analysis unit 103 outputs the list of weighted therapy suggestions and/or the members of the intersecting list to a display at the client terminal from which the functional image and/or the new multidimensional patient profile has been received.
It should be noted that though the multidimensional patient profiles 104, 105 may comprise information about the diagnosis that defines the impairment of health or the condition of abnormal functioning of the patient, the analysis unit 3 may ignore that information. In such a manner, the analysis unit 103 may output a therapy suggestion or a list of weighted therapy suggestions based on medical measurements only, without combining any opinions and/or conclusions of physicians or the like.
Optionally, a dimension of the multidimensional patient profiles 104, 105 is weighted. In such a manner, common parameters may effect the suggestion according to a weight that is associated therewith.
As described above, the system allows the matching of multidimensional profiles. Such a matching may require high computational complexity. In order to provide a short response time for analyzing, classifying, and/or diagnosing requests, the aforementioned matching is performed using a processing unit that has improved processing abilities in relation to the local processors of each one of the client terminals. Optionally, the central processing unit includes multiple processing units that combines a tightly coupled parallel architecture and/or in a loosely coupled distributed architecture.
Optionally, the response time of the central processing unit allows the matching of between the source image and the reference images and/or the new multidimensional patient profile 104 and the records of the reference patient database 102 in real time. In order to provide such a response rate, the multiple processing units may be processors with high processing capacity. Optionally, the multiple processing units are adapted to access large amounts of data. Optionally, each one of the multiple processing units has a multiple data bus, preferably 64-bit or 128-bit processing power, an arithmetic logic unit (ALU), and wide range of fast I/O channels.
Optionally, the system comprises a maintenance module that includes a control mechanism for data quality and data management in order to assure the reliability and availability of the reference patient database 102. Optionally, the maintenance module assures that the records of the reference patient database 102 are kept confidential, inter alia, in order to assure the privacy of the documented patient. Optionally, the maintenance module scores the quality of each record or batch of records that are uploaded to the reference patient database 102.
As described above, the input unit 101 optionally receives a source image that comprises a functional image, as shown at 104, and forwards it for processing by the analysis unit 103 in real time. In one embodiment of the present invention, the matching system 100 is used for allowing an imaging system to have active vision. As used herein, an imaging system with active vision means an imaging system that is able to interact with the imaged scene by altering its viewpoint rather than passively observing it, and by operating on sequences of images rather than on a single frame.
Reference is now made to
Optionally, such a process is used for repositioning the radiation detectors of the imaging system or determining the scanning pattern thereof, thereby improving the acquisition of parameters such as energy resolution, field of view, and/or scan pattern. The matching set, which is produced by the analysis unit 103, comprises a number of images that depicts respective tissues and optionally neighboring tissues. These images depict areas in which there may be irregular biological indications and/or pathological indications. Optionally, the analysis system identifies these irregularities by matching the members of the matching set with a model of a normal image and directs the radiation detectors of the imaging system toward these areas.
Optionally, such a process may be used for generating a continuous motion or step-wise motion for a set of detectors. As described above, the preliminary functional image is matched with a plurality of reference images. Such a matching may reduce the amount of radiation to which a patient is exposed, optionally by reducing the size of the area that is imaged. For example, if the matching set comprises one or more reference images with a certain pathological indication in a certain area, the analysis unit 103 outputs a refinement recommendation that directs the detectors toward another area that allows the analysis unit 103 to determine how to diagnose the pathological indication.
Optionally, a certain area is imaged using a limited number of detectors that sequentially scan sub-areas thereof In such an embodiment, the preliminary functional image, which is received at 202, is an image of one of the sub-areas. By analyzing the acquire data at a certain given time point, the matching set is used as shown at 203 and the next sub-area to be scanned is defined for the next time point. Such a closed loop imaging may be performed in a magnitude of scale of minutes, seconds, and fractions of seconds, such as 1/100th or 1/1000th of a second. Such an embodiment allows the detection of an onset of a biological activity, such as an arrhythmia or a brain activity, and may be used for adapting the scanning pattern according to the propagation and development of the onset.
In order to facilitate such an active vision, the reference images may include preliminary functional images, which are partially reconstructed images that have been taken during the acquisition thereof and/or of one or more segments of a certain area which is respective to the probed area.
Such an embodiment allows the imaging of a complex static scene in nonuniform resolution, thereby reduces the computational complexity of the imaging.
As described above, the process that is depicted in
Optionally, the reconstruction is performed in a voxel-by-voxel approach. The reconstructed variables are analyzed, fixed, and then further analyzed in a set of repeated steps, for example as depicted in
In an exemplary embodiment of the invention, the refinement recommendation includes instructions that define which ROI to scan next. Optionally, the refinement recommendation is based on an analysis that is provided from a matching set that suggests progression in patients with similar patient profile.
Possibly, the computation power that is used to analyze such a progression in real-time is high and may require a specialized computational system architecture. As described above, the analysis unit 103 may comprise a processing unit that includes multiple high speed CPUs and/or data processing systems (DPSs) that implement multiple data buses and/or 64 bit, 128 bit, and/or stronger CPU architectures.
Optionally, the refinement recommendation may be a selection of a new viewpoint and/or view parameters for one or more of the aforementioned detectors.
Optionally, the reference patient database 102 hosts a probability matrix, such as probability vector that define the probability that a photon emitted from points in space would be detected by the detector for each viewpoint. Such probability matrixes are used as part of the algorithms for estimating the detected photon counts from estimated intensities, and for other algorithmic steps.
Optionally, the reconstruction includes reconstruction of parameters associated with time-varying biological processes. In such an embodiment, some of the processes may require non-linear modeling of the process. In one embodiment, the matching system 100 allows the reconstruction of these parameters in real time, allowing a medical team to diagnose a patient or the progress of a therapeutic procedure immediately.
Optionally, the matching system 100 is designed to optimize the number of views which are necessary to obtain enough information for imaging by identifying when and/or where to acquire a certain preliminary image. As mentioned above, a certain biological activity may be an outcome of another biological activity. In such an embodiment, the biological activities that provide pathological indications may appear in a sequential manner and therefore the ROI should be defined in different locations at different time slots. Furthermore, if the reconstructed parameters are kinetics parameters, such as order of reaction, kinetic rate constant, apparent, intrinsic and diffusional activation energies and activation energy (Ea), the scanning pattern is planned according to an anticipated time curve. Optionally, the anticipated time curve is adjusted in real time.
In an exemplary embodiment of the present invention, the amount and/or complexity of the data that is acquired is reduced to enable easier image processing, image reconstruction, and/or categorization of the disease process. Information maximization and need to reduce complexity of procedure may be addressed in this approach. It may further allow reducing the volume of the relevant and essential data that is needed for making efficient use of resources, such as computational and/or storage resources.
It is expected that during the life of a patent maturing from this application many relevant systems and devices will be developed and the scope of the term a voxel, a pixel element, a patient profile, an imaging device, CT, MRI, and SPECT are intended to include all such new technologies a priori.
The terms “comprises”, “comprising”, “includes”, “including”, “having” and their conjugates mean “including but not limited to”. This term encompasses the terms “consisting of” and “consisting essentially of”.
As used herein, the singular form “a”, “an” and “the” include plural references unless the context clearly dictates otherwise.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.
All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.
The application is a National Phase Application of PCT Patent Application No. PCT/IL2007/001588 having International Filing Date of Dec. 20, 2007, which claims priority from U.S. Provisional Application No. 60/875,833, filed on Dec. 20, 2006. The contents of the above Application are all incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/IL2007/001588 | 12/20/2007 | WO | 00 | 1/12/2010 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2008/075362 | 6/26/2008 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 630611 | Knapp et al. | Aug 1899 | A |
| 2776377 | Anger | Jan 1957 | A |
| 3340866 | Nöller | Sep 1967 | A |
| 3446965 | Ogier et al. | May 1969 | A |
| 3535085 | Shumate et al. | Oct 1970 | A |
| 3684887 | Hugonin | Aug 1972 | A |
| 3690309 | Pluzhnikov et al. | Sep 1972 | A |
| 3719183 | Schwartz | Mar 1973 | A |
| 3739279 | Hollis | Jun 1973 | A |
| 3971362 | Pope et al. | Jul 1976 | A |
| 3978337 | Nickles et al. | Aug 1976 | A |
| 3988585 | O'Neill et al. | Oct 1976 | A |
| 4000502 | Butler et al. | Dec 1976 | A |
| 4015592 | Bradley-Moore | Apr 1977 | A |
| 4055765 | Gerber et al. | Oct 1977 | A |
| 4061919 | Miller et al. | Dec 1977 | A |
| 4095107 | Genna et al. | Jun 1978 | A |
| 4165462 | Macovski et al. | Aug 1979 | A |
| 4181856 | Bone | Jan 1980 | A |
| 4278077 | Mizumoto | Jul 1981 | A |
| 4289969 | Cooperstein et al. | Sep 1981 | A |
| 4291708 | Frei et al. | Sep 1981 | A |
| 4296785 | Vitello et al. | Oct 1981 | A |
| 4302675 | Wake et al. | Nov 1981 | A |
| 4364377 | Smith | Dec 1982 | A |
| 4383327 | Kruger | May 1983 | A |
| 4476381 | Rubin | Oct 1984 | A |
| 4503331 | Kovacs, Jr. et al. | Mar 1985 | A |
| 4521688 | Yin | Jun 1985 | A |
| H12 | Bennett et al. | Jan 1986 | H |
| 4580054 | Shimoni | Apr 1986 | A |
| 4595014 | Barrett et al. | Jun 1986 | A |
| 4674107 | Urban et al. | Jun 1987 | A |
| 4679142 | Lee | Jul 1987 | A |
| 4689041 | Corday et al. | Aug 1987 | A |
| 4689621 | Kleinberg | Aug 1987 | A |
| 4709382 | Sones | Nov 1987 | A |
| 4710624 | Alvarez et al. | Dec 1987 | A |
| 4731536 | Rische et al. | Mar 1988 | A |
| 4773430 | Porath | Sep 1988 | A |
| 4782840 | Martin, Jr. et al. | Nov 1988 | A |
| 4791934 | Brunnett | Dec 1988 | A |
| 4801803 | Denen et al. | Jan 1989 | A |
| 4828841 | Porter et al. | May 1989 | A |
| 4834112 | Machek et al. | May 1989 | A |
| 4844067 | Ikada et al. | Jul 1989 | A |
| 4844076 | Lesho et al. | Jul 1989 | A |
| 4853546 | Abe et al. | Aug 1989 | A |
| 4854324 | Hirschman et al. | Aug 1989 | A |
| 4854330 | Evans, III et al. | Aug 1989 | A |
| 4867962 | Abrams | Sep 1989 | A |
| 4893013 | Denen et al. | Jan 1990 | A |
| 4893322 | Hellmick et al. | Jan 1990 | A |
| 4919146 | Rhinehart et al. | Apr 1990 | A |
| 4924486 | Weber et al. | May 1990 | A |
| 4928250 | Greenberg et al. | May 1990 | A |
| 4929832 | Ledly | May 1990 | A |
| 4938230 | Machek et al. | Jul 1990 | A |
| 4951653 | Fry et al. | Aug 1990 | A |
| 4959547 | Carroll et al. | Sep 1990 | A |
| 4970391 | Uber, III | Nov 1990 | A |
| 4995396 | Inaba et al. | Feb 1991 | A |
| 5014708 | Hayashi et al. | May 1991 | A |
| 5018182 | Cowan et al. | May 1991 | A |
| 5032729 | Charpak | Jul 1991 | A |
| 5033998 | Corday et al. | Jul 1991 | A |
| 5039863 | Matsuno et al. | Aug 1991 | A |
| 5042056 | Hellmick et al. | Aug 1991 | A |
| 5070877 | Mohiuddin et al. | Dec 1991 | A |
| 5070878 | Denen | Dec 1991 | A |
| 5088492 | Takayama et al. | Feb 1992 | A |
| 5115137 | Andersson-Engels et al. | May 1992 | A |
| 5119818 | Carroll et al. | Jun 1992 | A |
| 5132542 | Bassalleck et al. | Jul 1992 | A |
| 5142557 | Toker et al. | Aug 1992 | A |
| 5145163 | Cowan et al. | Sep 1992 | A |
| 5151598 | Denen | Sep 1992 | A |
| 5170055 | Carroll et al. | Dec 1992 | A |
| 5170439 | Zeng et al. | Dec 1992 | A |
| 5170789 | Narayan et al. | Dec 1992 | A |
| 5196796 | Misic et al. | Mar 1993 | A |
| 5210421 | Gullberg et al. | May 1993 | A |
| 5243988 | Sieben et al. | Sep 1993 | A |
| 5246005 | Carroll et al. | Sep 1993 | A |
| 5249124 | DeVito | Sep 1993 | A |
| 5252830 | Weinberg | Oct 1993 | A |
| 5254101 | Trombley, III | Oct 1993 | A |
| 5258717 | Misic et al. | Nov 1993 | A |
| 5263077 | Cowan et al. | Nov 1993 | A |
| 5279607 | Schentag et al. | Jan 1994 | A |
| 5284147 | Hanaoka et al. | Feb 1994 | A |
| 5299253 | Wessels | Mar 1994 | A |
| 5304165 | Haber et al. | Apr 1994 | A |
| 5307808 | Dumoulin et al. | May 1994 | A |
| 5307814 | Kressel et al. | May 1994 | A |
| 5309959 | Shaw et al. | May 1994 | A |
| 5317506 | Coutre et al. | May 1994 | A |
| 5317619 | Hellmick et al. | May 1994 | A |
| 5323006 | Thompson et al. | Jun 1994 | A |
| 5329976 | Haber et al. | Jul 1994 | A |
| 5334141 | Carr et al. | Aug 1994 | A |
| 5349190 | Hines et al. | Sep 1994 | A |
| 5355087 | Claiborne et al. | Oct 1994 | A |
| 5365069 | Eisen et al. | Nov 1994 | A |
| 5365928 | Rhinehart et al. | Nov 1994 | A |
| 5367552 | Peschmann | Nov 1994 | A |
| 5377681 | Drane | Jan 1995 | A |
| 5381791 | Qian | Jan 1995 | A |
| 5383456 | Arnold et al. | Jan 1995 | A |
| 5383858 | Reilly et al. | Jan 1995 | A |
| 5386446 | Fujimoto et al. | Jan 1995 | A |
| 5387409 | Nunn et al. | Feb 1995 | A |
| 5391877 | Marks | Feb 1995 | A |
| 5395366 | D'Andrea | Mar 1995 | A |
| 5396531 | Hartley | Mar 1995 | A |
| 5399868 | Jones et al. | Mar 1995 | A |
| 5404293 | Weng et al. | Apr 1995 | A |
| 5415181 | Hofgrefe et al. | May 1995 | A |
| 5431161 | Ryals et al. | Jul 1995 | A |
| 5435302 | Lenkinski et al. | Jul 1995 | A |
| 5436458 | Tran et al. | Jul 1995 | A |
| 5441050 | Thurston et al. | Aug 1995 | A |
| 5448073 | Jeanguillaume | Sep 1995 | A |
| 5451232 | Rhinehart et al. | Sep 1995 | A |
| 5472403 | Cornacchia et al. | Dec 1995 | A |
| 5475219 | Olson | Dec 1995 | A |
| 5475232 | Powers et al. | Dec 1995 | A |
| 5476095 | Schnall et al. | Dec 1995 | A |
| 5479969 | Hardie et al. | Jan 1996 | A |
| 5481115 | Hsieh et al. | Jan 1996 | A |
| 5484384 | Fearnot | Jan 1996 | A |
| 5489782 | Wernikoff | Feb 1996 | A |
| 5493595 | Schoolman | Feb 1996 | A |
| 5493805 | Penuela et al. | Feb 1996 | A |
| 5494036 | Uber, III et al. | Feb 1996 | A |
| 5501674 | Trombley, III et al. | Mar 1996 | A |
| 5517120 | Misik et al. | May 1996 | A |
| 5519221 | Weinberg | May 1996 | A |
| 5519222 | Besett | May 1996 | A |
| 5519931 | Reich | May 1996 | A |
| 5520182 | Leighton et al. | May 1996 | A |
| 5520653 | Reilly et al. | May 1996 | A |
| 5521506 | Misic et al. | May 1996 | A |
| 5536945 | Reich | Jul 1996 | A |
| 5545899 | Tran et al. | Aug 1996 | A |
| 5559335 | Zeng et al. | Sep 1996 | A |
| 5565684 | Gullberg et al. | Oct 1996 | A |
| 5569181 | Heilman et al. | Oct 1996 | A |
| 5572132 | Pulyer et al. | Nov 1996 | A |
| 5572999 | Funda et al. | Nov 1996 | A |
| 5579766 | Gray | Dec 1996 | A |
| 5580541 | Wells et al. | Dec 1996 | A |
| 5585637 | Bertelsen et al. | Dec 1996 | A |
| 5587585 | Eisen et al. | Dec 1996 | A |
| 5591143 | Trombley, III et al. | Jan 1997 | A |
| 5600145 | Plummer | Feb 1997 | A |
| 5604531 | Iddan et al. | Feb 1997 | A |
| 5610520 | Misic | Mar 1997 | A |
| 5617858 | Taverna et al. | Apr 1997 | A |
| 5629524 | Stettner et al. | May 1997 | A |
| 5630034 | Oikawa et al. | May 1997 | A |
| 5635717 | Popescu | Jun 1997 | A |
| 5657759 | Essen-Moller | Aug 1997 | A |
| 5672877 | Liebig et al. | Sep 1997 | A |
| 5677539 | Apotovsky et al. | Oct 1997 | A |
| 5682888 | Olson et al. | Nov 1997 | A |
| 5687250 | Curley et al. | Nov 1997 | A |
| 5687542 | Lawecki et al. | Nov 1997 | A |
| 5690691 | Chen et al. | Nov 1997 | A |
| 5692640 | Caulfield et al. | Dec 1997 | A |
| 5694933 | Madden et al. | Dec 1997 | A |
| 5695500 | Taylor et al. | Dec 1997 | A |
| 5716595 | Goldenberg | Feb 1998 | A |
| 5727554 | Kalend et al. | Mar 1998 | A |
| 5729129 | Acker | Mar 1998 | A |
| 5732704 | Thurston et al. | Mar 1998 | A |
| 5739508 | Uber, III | Apr 1998 | A |
| 5741232 | Reilly et al. | Apr 1998 | A |
| 5742060 | Ashburn | Apr 1998 | A |
| 5744805 | Raylman et al. | Apr 1998 | A |
| 5757006 | De Vito et al. | May 1998 | A |
| 5779675 | Reilly et al. | Jul 1998 | A |
| 5780855 | Pare et al. | Jul 1998 | A |
| 5781442 | Engleson et al. | Jul 1998 | A |
| 5784432 | Kurtz et al. | Jul 1998 | A |
| 5786597 | Lingren et al. | Jul 1998 | A |
| 5795333 | Reilly et al. | Aug 1998 | A |
| 5799111 | Guissin | Aug 1998 | A |
| 5800355 | Hasegawa | Sep 1998 | A |
| 5803914 | Ryals et al. | Sep 1998 | A |
| 5806519 | Evans, III et al. | Sep 1998 | A |
| 5808203 | Nolan, Jr. et al. | Sep 1998 | A |
| 5810742 | Pearlman | Sep 1998 | A |
| 5811814 | Leone et al. | Sep 1998 | A |
| 5813985 | Carroll | Sep 1998 | A |
| 5818050 | Dilmanian et al. | Oct 1998 | A |
| 5821541 | Tümer | Oct 1998 | A |
| 5825031 | Wong et al. | Oct 1998 | A |
| 5827219 | Uber, III et al. | Oct 1998 | A |
| 5828073 | Zhu et al. | Oct 1998 | A |
| 5833603 | Kovacs et al. | Nov 1998 | A |
| 5838009 | Plummer et al. | Nov 1998 | A |
| 5840026 | Uber, III et al. | Nov 1998 | A |
| 5841141 | Gullberg et al. | Nov 1998 | A |
| 5842977 | Lesho et al. | Dec 1998 | A |
| 5843037 | Uber, III | Dec 1998 | A |
| 5846513 | Carroll et al. | Dec 1998 | A |
| 5847396 | Lingren et al. | Dec 1998 | A |
| 5857463 | Thurston et al. | Jan 1999 | A |
| 5871013 | Wainer et al. | Feb 1999 | A |
| 5873861 | Hitchins et al. | Feb 1999 | A |
| 5880475 | Oka et al. | Mar 1999 | A |
| 5882338 | Gray | Mar 1999 | A |
| 5884457 | Ortiz et al. | Mar 1999 | A |
| 5885216 | Evans, III et al. | Mar 1999 | A |
| 5891030 | Johnson et al. | Apr 1999 | A |
| 5893397 | Peterson et al. | Apr 1999 | A |
| 5899885 | Reilly et al. | May 1999 | A |
| 5900533 | Chou | May 1999 | A |
| 5903008 | Li | May 1999 | A |
| 5910112 | Judd et al. | Jun 1999 | A |
| 5911252 | Cassel | Jun 1999 | A |
| 5916167 | Kramer et al. | Jun 1999 | A |
| 5916197 | Reilly et al. | Jun 1999 | A |
| 5920054 | Uber, III | Jul 1999 | A |
| 5927351 | Zhu et al. | Jul 1999 | A |
| 5928150 | Call | Jul 1999 | A |
| 5932879 | Raylman et al. | Aug 1999 | A |
| 5938639 | Reilly et al. | Aug 1999 | A |
| 5939724 | Eisen et al. | Aug 1999 | A |
| 5944190 | Edelen | Aug 1999 | A |
| 5944694 | Hitchins et al. | Aug 1999 | A |
| 5947935 | Rhinehart et al. | Sep 1999 | A |
| 5953884 | Lawecki et al. | Sep 1999 | A |
| 5954668 | Uber, III et al. | Sep 1999 | A |
| 5961457 | Raylman et al. | Oct 1999 | A |
| 5967983 | Ashburn | Oct 1999 | A |
| 5973598 | Beigel | Oct 1999 | A |
| 5974165 | Giger et al. | Oct 1999 | A |
| 5984860 | Shan | Nov 1999 | A |
| 5987350 | Thurston | Nov 1999 | A |
| 5993378 | Lemelson | Nov 1999 | A |
| 5997502 | Reilly et al. | Dec 1999 | A |
| 6002134 | Lingren | Dec 1999 | A |
| 6002480 | Izatt et al. | Dec 1999 | A |
| 6017330 | Hitchins et al. | Jan 2000 | A |
| 6019745 | Gray | Feb 2000 | A |
| 6021341 | Scibilia et al. | Feb 2000 | A |
| 6026317 | Verani | Feb 2000 | A |
| 6037595 | Lingren | Mar 2000 | A |
| 6040697 | Misic | Mar 2000 | A |
| 6042565 | Hirschman et al. | Mar 2000 | A |
| RE36648 | Uber, III et al. | Apr 2000 | E |
| 6046454 | Lingren et al. | Apr 2000 | A |
| 6048334 | Hirschman et al. | Apr 2000 | A |
| 6052618 | Dahlke et al. | Apr 2000 | A |
| 6055450 | Ashburn | Apr 2000 | A |
| 6055452 | Pearlman | Apr 2000 | A |
| RE36693 | Reich | May 2000 | E |
| 6063052 | Uber, III et al. | May 2000 | A |
| D426891 | Beale et al. | Jun 2000 | S |
| D426892 | Beale et al. | Jun 2000 | S |
| 6072177 | McCroskey et al. | Jun 2000 | A |
| 6076009 | Raylman et al. | Jun 2000 | A |
| 6080984 | Friesenhahn | Jun 2000 | A |
| D428491 | Beale et al. | Jul 2000 | S |
| 6082366 | Andra et al. | Jul 2000 | A |
| 6090064 | Reilly et al. | Jul 2000 | A |
| 6091070 | Lingren et al. | Jul 2000 | A |
| 6096011 | Trombley, III et al. | Aug 2000 | A |
| 6107102 | Ferrari | Aug 2000 | A |
| 6115635 | Bourgeois | Sep 2000 | A |
| 6129670 | Burdette et al. | Oct 2000 | A |
| 6132372 | Essen-Moller | Oct 2000 | A |
| 6135955 | Madden et al. | Oct 2000 | A |
| 6135968 | Brounstein | Oct 2000 | A |
| 6137109 | Hayes | Oct 2000 | A |
| 6145277 | Lawecki et al. | Nov 2000 | A |
| 6147352 | Ashburn | Nov 2000 | A |
| 6147353 | Gagnon et al. | Nov 2000 | A |
| 6148229 | Morris, Sr. et al. | Nov 2000 | A |
| 6149627 | Uber, III | Nov 2000 | A |
| 6155485 | Coughlin et al. | Dec 2000 | A |
| 6160398 | Walsh | Dec 2000 | A |
| 6162198 | Coffey et al. | Dec 2000 | A |
| 6172362 | Lingren et al. | Jan 2001 | B1 |
| 6173201 | Front | Jan 2001 | B1 |
| 6184530 | Hines et al. | Feb 2001 | B1 |
| 6189195 | Reilly et al. | Feb 2001 | B1 |
| 6194715 | Lingren et al. | Feb 2001 | B1 |
| 6194725 | Colsher et al. | Feb 2001 | B1 |
| 6194726 | Pi et al. | Feb 2001 | B1 |
| 6197000 | Reilly et al. | Mar 2001 | B1 |
| 6202923 | Boyer et al. | Mar 2001 | B1 |
| 6203775 | Torchilin et al. | Mar 2001 | B1 |
| 6205347 | Morgan et al. | Mar 2001 | B1 |
| 6212423 | Krakovitz | Apr 2001 | B1 |
| 6223065 | Misic et al. | Apr 2001 | B1 |
| 6224577 | Dedola et al. | May 2001 | B1 |
| 6226350 | Hsieh | May 2001 | B1 |
| 6229145 | Weinberg | May 2001 | B1 |
| 6232605 | Soluri et al. | May 2001 | B1 |
| 6233304 | Hu et al. | May 2001 | B1 |
| 6236050 | Tumer | May 2001 | B1 |
| 6236878 | Taylor et al. | May 2001 | B1 |
| 6236880 | Raylman et al. | May 2001 | B1 |
| 6239438 | Schubert | May 2001 | B1 |
| 6240312 | Alfano et al. | May 2001 | B1 |
| 6241708 | Reilly et al. | Jun 2001 | B1 |
| 6242743 | DeVito | Jun 2001 | B1 |
| 6242744 | Soluri et al. | Jun 2001 | B1 |
| 6242745 | Berlad et al. | Jun 2001 | B1 |
| 6246901 | Benaron | Jun 2001 | B1 |
| 6252924 | Davantes et al. | Jun 2001 | B1 |
| 6258576 | Richards-Kortum et al. | Jul 2001 | B1 |
| 6259095 | Bouton et al. | Jul 2001 | B1 |
| 6261562 | Xu et al. | Jul 2001 | B1 |
| 6263229 | Atalar et al. | Jul 2001 | B1 |
| 6269340 | Ford et al. | Jul 2001 | B1 |
| 6270463 | Morris, Sr. et al. | Aug 2001 | B1 |
| 6271524 | Wainer et al. | Aug 2001 | B1 |
| 6271525 | Majewski et al. | Aug 2001 | B1 |
| 6280704 | Schutt et al. | Aug 2001 | B1 |
| 6281505 | Hines et al. | Aug 2001 | B1 |
| 6308097 | Pearlman | Oct 2001 | B1 |
| 6310968 | Hawkins et al. | Oct 2001 | B1 |
| 6315981 | Unger | Nov 2001 | B1 |
| 6317623 | Griffiths et al. | Nov 2001 | B1 |
| 6317648 | Sleep et al. | Nov 2001 | B1 |
| 6318630 | Coughlin et al. | Nov 2001 | B1 |
| 6322535 | Hitchins et al. | Nov 2001 | B1 |
| 6323648 | Belt et al. | Nov 2001 | B1 |
| 6324418 | Crowley et al. | Nov 2001 | B1 |
| RE37487 | Reilly et al. | Dec 2001 | E |
| D452737 | Nolan, Jr. et al. | Jan 2002 | S |
| 6336913 | Spohn et al. | Jan 2002 | B1 |
| 6339652 | Hawkins et al. | Jan 2002 | B1 |
| 6339718 | Zatezalo et al. | Jan 2002 | B1 |
| 6344745 | Reisker et al. | Feb 2002 | B1 |
| 6346706 | Rogers et al. | Feb 2002 | B1 |
| 6346886 | de la Huerga | Feb 2002 | B1 |
| RE37602 | Uber, III et al. | Mar 2002 | E |
| 6353227 | Boxen | Mar 2002 | B1 |
| 6356081 | Misic | Mar 2002 | B1 |
| 6368331 | Front et al. | Apr 2002 | B1 |
| 6371938 | Reilly et al. | Apr 2002 | B1 |
| 6375624 | Uber, III et al. | Apr 2002 | B1 |
| 6377838 | Iwanczyk et al. | Apr 2002 | B1 |
| 6381349 | Zeng et al. | Apr 2002 | B1 |
| 6385483 | Uber, III et al. | May 2002 | B1 |
| 6388244 | Gagnon | May 2002 | B1 |
| 6388258 | Berlad et al. | May 2002 | B1 |
| 6392235 | Barrett et al. | May 2002 | B1 |
| 6396273 | Misic | May 2002 | B2 |
| 6397098 | Uber, III et al. | May 2002 | B1 |
| 6399951 | Paulus et al. | Jun 2002 | B1 |
| 6402717 | Reilly et al. | Jun 2002 | B1 |
| 6402718 | Reilly et al. | Jun 2002 | B1 |
| 6407391 | Mastrippolito et al. | Jun 2002 | B1 |
| 6408204 | Hirschman | Jun 2002 | B1 |
| 6409987 | Cardin et al. | Jun 2002 | B1 |
| 6415046 | Kerut, Sr. | Jul 2002 | B1 |
| 6420711 | Tuemer | Jul 2002 | B2 |
| 6425174 | Reich | Jul 2002 | B1 |
| 6426917 | Tabanou et al. | Jul 2002 | B1 |
| 6429431 | Wilk | Aug 2002 | B1 |
| 6431175 | Penner et al. | Aug 2002 | B1 |
| 6432089 | Kakimi et al. | Aug 2002 | B1 |
| 6438401 | Cheng et al. | Aug 2002 | B1 |
| 6439444 | Shields, II | Aug 2002 | B1 |
| 6440107 | Trombley, III et al. | Aug 2002 | B1 |
| 6442418 | Evans, III et al. | Aug 2002 | B1 |
| 6448560 | Tumer | Sep 2002 | B1 |
| 6453199 | Kobozev | Sep 2002 | B1 |
| 6459925 | Nields et al. | Oct 2002 | B1 |
| 6459931 | Hirschman | Oct 2002 | B1 |
| 6468261 | Small et al. | Oct 2002 | B1 |
| 6469306 | Van Dulmen et al. | Oct 2002 | B1 |
| 6471674 | Emig et al. | Oct 2002 | B1 |
| 6480732 | Tanaka et al. | Nov 2002 | B1 |
| 6484051 | Daniel | Nov 2002 | B1 |
| 6488661 | Spohn et al. | Dec 2002 | B1 |
| 6490476 | Townsend et al. | Dec 2002 | B1 |
| 6504157 | Juhi | Jan 2003 | B2 |
| 6504178 | Carlson et al. | Jan 2003 | B2 |
| 6504899 | Pugachev et al. | Jan 2003 | B2 |
| 6506155 | Sluis et al. | Jan 2003 | B2 |
| 6510336 | Daghighian et al. | Jan 2003 | B1 |
| 6512374 | Misic et al. | Jan 2003 | B1 |
| 6516213 | Nevo | Feb 2003 | B1 |
| 6519569 | White et al. | Feb 2003 | B1 |
| 6520930 | Critchlow et al. | Feb 2003 | B2 |
| 6522945 | Sleep et al. | Feb 2003 | B2 |
| 6525320 | Juni | Feb 2003 | B1 |
| 6525321 | Juni | Feb 2003 | B2 |
| 6541763 | Lingren et al. | Apr 2003 | B2 |
| 6545280 | Weinberg | Apr 2003 | B2 |
| 6549646 | Yeh et al. | Apr 2003 | B1 |
| 6560354 | Maurer et al. | May 2003 | B1 |
| 6562008 | Reilly et al. | May 2003 | B1 |
| 6563942 | Takeo et al. | May 2003 | B2 |
| 6565502 | Bede et al. | May 2003 | B1 |
| 6567687 | Front et al. | May 2003 | B2 |
| 6574304 | Hsieh et al. | Jun 2003 | B1 |
| 6575930 | Trombley, III et al. | Jun 2003 | B1 |
| 6576918 | Fu et al. | Jun 2003 | B1 |
| 6583420 | Nelson et al. | Jun 2003 | B1 |
| 6584348 | Glukhovsky | Jun 2003 | B2 |
| 6585700 | Trocki et al. | Jul 2003 | B1 |
| 6587710 | Wainer | Jul 2003 | B1 |
| 6589158 | Winkler | Jul 2003 | B2 |
| 6591127 | McKinnon | Jul 2003 | B1 |
| 6592520 | Peszynski et al. | Jul 2003 | B1 |
| 6602488 | Daghighian | Aug 2003 | B1 |
| 6607301 | Glukhovsky et al. | Aug 2003 | B1 |
| 6611141 | Schulz et al. | Aug 2003 | B1 |
| 6614453 | Suri et al. | Sep 2003 | B1 |
| 6620134 | Trombley, III et al. | Sep 2003 | B1 |
| 6627893 | Zeng et al. | Sep 2003 | B1 |
| 6628983 | Gagnon | Sep 2003 | B1 |
| 6628984 | Weinberg | Sep 2003 | B2 |
| 6630735 | Carlson et al. | Oct 2003 | B1 |
| 6631284 | Nutt et al. | Oct 2003 | B2 |
| 6632216 | Houzego et al. | Oct 2003 | B2 |
| 6633658 | Dabney et al. | Oct 2003 | B1 |
| 6638752 | Contag et al. | Oct 2003 | B2 |
| 6643537 | Zatezalo et al. | Nov 2003 | B1 |
| 6643538 | Majewski et al. | Nov 2003 | B1 |
| 6652489 | Trocki et al. | Nov 2003 | B2 |
| 6657200 | Nygard et al. | Dec 2003 | B2 |
| 6662036 | Cosman | Dec 2003 | B2 |
| 6664542 | Ye et al. | Dec 2003 | B2 |
| 6670258 | Carlson et al. | Dec 2003 | B2 |
| 6671563 | Engelson et al. | Dec 2003 | B1 |
| 6673033 | Sciulli et al. | Jan 2004 | B1 |
| 6674834 | Acharya et al. | Jan 2004 | B1 |
| 6676634 | Spohn et al. | Jan 2004 | B1 |
| 6677182 | Carlson et al. | Jan 2004 | B2 |
| 6677755 | Belt et al. | Jan 2004 | B2 |
| 6680750 | Tournier et al. | Jan 2004 | B1 |
| 6694172 | Gagnon et al. | Feb 2004 | B1 |
| 6697660 | Robinson | Feb 2004 | B1 |
| 6699219 | Emig et al. | Mar 2004 | B2 |
| 6704592 | Reynolds et al. | Mar 2004 | B1 |
| 6713766 | Garrard et al. | Mar 2004 | B2 |
| 6714012 | Belt et al. | Mar 2004 | B2 |
| 6714013 | Misic | Mar 2004 | B2 |
| 6716195 | Nolan, Jr. et al. | Apr 2004 | B2 |
| 6722499 | Reich | Apr 2004 | B2 |
| 6723988 | Wainer | Apr 2004 | B1 |
| 6726657 | Dedig et al. | Apr 2004 | B1 |
| 6728583 | Hallett | Apr 2004 | B2 |
| 6731971 | Evans, III et al. | May 2004 | B2 |
| 6731989 | Engleson et al. | May 2004 | B2 |
| 6733477 | Cowan et al. | May 2004 | B2 |
| 6733478 | Reilly et al. | May 2004 | B2 |
| 6734416 | Carlson et al. | May 2004 | B2 |
| 6734430 | Soluri et al. | May 2004 | B2 |
| 6737652 | Lanza et al. | May 2004 | B2 |
| 6737866 | Belt et al. | May 2004 | B2 |
| 6740882 | Weinberg et al. | May 2004 | B2 |
| 6743202 | Hirschman et al. | Jun 2004 | B2 |
| 6743205 | Nolan, Jr. et al. | Jun 2004 | B2 |
| 6747454 | Belt | Jun 2004 | B2 |
| 6748259 | Benaron et al. | Jun 2004 | B1 |
| 6751500 | Hirschman et al. | Jun 2004 | B2 |
| 6765981 | Heumann | Jul 2004 | B2 |
| 6766048 | Launay et al. | Jul 2004 | B1 |
| 6771802 | Patt et al. | Aug 2004 | B1 |
| 6774358 | Hamill et al. | Aug 2004 | B2 |
| 6776977 | Liu | Aug 2004 | B2 |
| 6787777 | Gagnon et al. | Sep 2004 | B1 |
| 6788758 | De Villiers | Sep 2004 | B2 |
| 6798206 | Misic | Sep 2004 | B2 |
| 6808513 | Reilly et al. | Oct 2004 | B2 |
| 6809321 | Rempel | Oct 2004 | B2 |
| 6813868 | Baldwin et al. | Nov 2004 | B2 |
| 6821013 | Reilly et al. | Nov 2004 | B2 |
| 6822237 | Inoue et al. | Nov 2004 | B2 |
| 6833705 | Misic | Dec 2004 | B2 |
| 6838672 | Wagenaar et al. | Jan 2005 | B2 |
| 6841782 | Balan et al. | Jan 2005 | B1 |
| 6843357 | Bybee et al. | Jan 2005 | B2 |
| 6851615 | Jones | Feb 2005 | B2 |
| 6866654 | Callan et al. | Mar 2005 | B2 |
| 6870175 | Dell et al. | Mar 2005 | B2 |
| 6881043 | Barak | Apr 2005 | B2 |
| 6888351 | Belt et al. | May 2005 | B2 |
| 6889074 | Uber, III et al. | May 2005 | B2 |
| 6897658 | Belt et al. | May 2005 | B2 |
| 6906330 | Blevis et al. | Jun 2005 | B2 |
| D507832 | Yanniello et al. | Jul 2005 | S |
| 6915170 | Engleson et al. | Jul 2005 | B2 |
| 6915823 | Osborne et al. | Jul 2005 | B2 |
| 6917828 | Fukuda | Jul 2005 | B2 |
| 6921384 | Reilly et al. | Jul 2005 | B2 |
| 6928142 | Shao et al. | Aug 2005 | B2 |
| 6935560 | Andreasson et al. | Aug 2005 | B2 |
| 6936030 | Pavlik et al. | Aug 2005 | B1 |
| 6937750 | Natanzon et al. | Aug 2005 | B2 |
| 6939302 | Griffiths et al. | Sep 2005 | B2 |
| 6940070 | Tumer | Sep 2005 | B2 |
| 6943355 | Shwartz et al. | Sep 2005 | B2 |
| 6957522 | Baldwin et al. | Oct 2005 | B2 |
| 6958053 | Reilly | Oct 2005 | B1 |
| 6963770 | Scarantino et al. | Nov 2005 | B2 |
| 6970735 | Uber, III et al. | Nov 2005 | B2 |
| 6972001 | Emig et al. | Dec 2005 | B2 |
| 6974443 | Reilly et al. | Dec 2005 | B2 |
| 6976349 | Baldwin et al. | Dec 2005 | B2 |
| 6984222 | Hitchins et al. | Jan 2006 | B1 |
| 6985870 | Martucci et al. | Jan 2006 | B2 |
| 6988981 | Hamazaki | Jan 2006 | B2 |
| 6994249 | Peterka et al. | Feb 2006 | B2 |
| 7009183 | Wainer et al. | Mar 2006 | B2 |
| 7011814 | Suddarth et al. | Mar 2006 | B2 |
| 7012430 | Misic | Mar 2006 | B2 |
| 7017622 | Osborne et al. | Mar 2006 | B2 |
| 7018363 | Cowan et al. | Mar 2006 | B2 |
| 7019783 | Kindem et al. | Mar 2006 | B2 |
| 7025757 | Reilly et al. | Apr 2006 | B2 |
| 7026623 | Oaknin et al. | Apr 2006 | B2 |
| 7043063 | Noble et al. | May 2006 | B1 |
| 7102138 | Belvis et al. | Sep 2006 | B2 |
| 7103204 | Celler et al. | Sep 2006 | B1 |
| 7127026 | Amemiya et al. | Oct 2006 | B2 |
| 7142634 | Engler et al. | Nov 2006 | B2 |
| 7145986 | Wear et al. | Dec 2006 | B2 |
| 7147372 | Nelson et al. | Dec 2006 | B2 |
| 7164130 | Welsh et al. | Jan 2007 | B2 |
| 7176466 | Rousso et al. | Feb 2007 | B2 |
| 7187790 | Sabol et al. | Mar 2007 | B2 |
| 7217953 | Carlson | May 2007 | B2 |
| 7256386 | Carlson et al. | Aug 2007 | B2 |
| 7291841 | Nelson et al. | Nov 2007 | B2 |
| 7327822 | Sauer et al. | Feb 2008 | B2 |
| 7359535 | Salla et al. | Apr 2008 | B2 |
| 7373197 | Daighighian et al. | May 2008 | B2 |
| 7394923 | Zou et al. | Jul 2008 | B2 |
| 7444010 | De Man | Oct 2008 | B2 |
| 7468513 | Charron et al. | Dec 2008 | B2 |
| 7470896 | Pawlak et al. | Dec 2008 | B2 |
| 7490085 | Walker et al. | Feb 2009 | B2 |
| 7495225 | Hefetz et al. | Feb 2009 | B2 |
| 7502499 | Grady | Mar 2009 | B2 |
| 7570732 | Stanton et al. | Aug 2009 | B2 |
| 7592597 | Hefetz et al. | Sep 2009 | B2 |
| 7620444 | Le et al. | Nov 2009 | B2 |
| 7627084 | Jabri et al. | Dec 2009 | B2 |
| 7652259 | Kimchy et al. | Jan 2010 | B2 |
| 7671331 | Hefetz | Mar 2010 | B2 |
| 7671340 | Uribe et al. | Mar 2010 | B2 |
| 7672491 | Krishnan et al. | Mar 2010 | B2 |
| 7680240 | Manjeshwar et al. | Mar 2010 | B2 |
| 7705316 | Rousso et al. | Apr 2010 | B2 |
| 7734331 | Dhawale et al. | Jun 2010 | B2 |
| 7826889 | David et al. | Nov 2010 | B2 |
| 7831024 | Metzler et al. | Nov 2010 | B2 |
| 7835927 | Schlotterbeck et al. | Nov 2010 | B2 |
| 7872235 | Rousso et al. | Jan 2011 | B2 |
| 7894650 | Weng et al. | Feb 2011 | B2 |
| 7968851 | Rousso et al. | Jun 2011 | B2 |
| 8013308 | Guerin et al. | Sep 2011 | B2 |
| 8055329 | Kimchy et al. | Nov 2011 | B2 |
| 8111886 | Rousso et al. | Feb 2012 | B2 |
| 8158951 | Bal et al. | Apr 2012 | B2 |
| 8163661 | Akiyoshi et al. | Apr 2012 | B2 |
| 8204500 | Weintraub et al. | Jun 2012 | B2 |
| 8338788 | Zilberstein et al. | Dec 2012 | B2 |
| 8440168 | Yang et al. | May 2013 | B2 |
| 20010016029 | Tumer | Aug 2001 | A1 |
| 20010020131 | Kawagishi et al. | Sep 2001 | A1 |
| 20010035902 | Iddan et al. | Nov 2001 | A1 |
| 20010049608 | Hochman | Dec 2001 | A1 |
| 20020068864 | Bishop et al. | Jun 2002 | A1 |
| 20020072784 | Sheppard, Jr. et al. | Jun 2002 | A1 |
| 20020085748 | Baumberg | Jul 2002 | A1 |
| 20020087101 | Barrick et al. | Jul 2002 | A1 |
| 20020099295 | Gil et al. | Jul 2002 | A1 |
| 20020099310 | Kimchy et al. | Jul 2002 | A1 |
| 20020099334 | Hanson et al. | Jul 2002 | A1 |
| 20020103429 | DeCharms | Aug 2002 | A1 |
| 20020103431 | Toker et al. | Aug 2002 | A1 |
| 20020145114 | Inoue et al. | Oct 2002 | A1 |
| 20020148970 | Wong et al. | Oct 2002 | A1 |
| 20020165491 | Reilly | Nov 2002 | A1 |
| 20020168094 | Kaushikkar et al. | Nov 2002 | A1 |
| 20020168317 | Daighighian et al. | Nov 2002 | A1 |
| 20020172405 | Schultz | Nov 2002 | A1 |
| 20020179843 | Tanaka et al. | Dec 2002 | A1 |
| 20020183645 | Nachaliel | Dec 2002 | A1 |
| 20020188197 | Bishop et al. | Dec 2002 | A1 |
| 20020191734 | Kojima et al. | Dec 2002 | A1 |
| 20020198738 | Osborne | Dec 2002 | A1 |
| 20030001098 | Stoddart et al. | Jan 2003 | A1 |
| 20030001837 | Baumberg | Jan 2003 | A1 |
| 20030006376 | Tumer | Jan 2003 | A1 |
| 20030013950 | Rollo et al. | Jan 2003 | A1 |
| 20030013966 | Barnes et al. | Jan 2003 | A1 |
| 20030038240 | Weinberg | Feb 2003 | A1 |
| 20030055685 | Cobb et al. | Mar 2003 | A1 |
| 20030063787 | Natanzon et al. | Apr 2003 | A1 |
| 20030071219 | Motomura et al. | Apr 2003 | A1 |
| 20030081716 | Tumer | May 2003 | A1 |
| 20030135388 | Martucci et al. | Jul 2003 | A1 |
| 20030136912 | Juni | Jul 2003 | A1 |
| 20030144322 | Kozikowski et al. | Jul 2003 | A1 |
| 20030147887 | Wang et al. | Aug 2003 | A1 |
| 20030158481 | Stotzka et al. | Aug 2003 | A1 |
| 20030174804 | Bulkes et al. | Sep 2003 | A1 |
| 20030183226 | Brand et al. | Oct 2003 | A1 |
| 20030189174 | Tanaka et al. | Oct 2003 | A1 |
| 20030191430 | D'Andrea et al. | Oct 2003 | A1 |
| 20030202629 | Dunham et al. | Oct 2003 | A1 |
| 20030208117 | Shwartz et al. | Nov 2003 | A1 |
| 20030215122 | Tanaka | Nov 2003 | A1 |
| 20030215124 | Li | Nov 2003 | A1 |
| 20030216631 | Bloch et al. | Nov 2003 | A1 |
| 20030219149 | Vailaya et al. | Nov 2003 | A1 |
| 20040003001 | Shimura | Jan 2004 | A1 |
| 20040010397 | Barbour et al. | Jan 2004 | A1 |
| 20040015075 | Kimchy et al. | Jan 2004 | A1 |
| 20040021065 | Weber | Feb 2004 | A1 |
| 20040044282 | Mixon et al. | Mar 2004 | A1 |
| 20040051368 | Caputo et al. | Mar 2004 | A1 |
| 20040054248 | Kimchy et al. | Mar 2004 | A1 |
| 20040054278 | Kimchy et al. | Mar 2004 | A1 |
| 20040065838 | Tumer | Apr 2004 | A1 |
| 20040075058 | Blevis et al. | Apr 2004 | A1 |
| 20040081623 | Eriksen et al. | Apr 2004 | A1 |
| 20040082918 | Evans et al. | Apr 2004 | A1 |
| 20040084340 | Morelle et al. | May 2004 | A1 |
| 20040086437 | Jackson et al. | May 2004 | A1 |
| 20040101176 | Mendonca et al. | May 2004 | A1 |
| 20040101177 | Zahlmann et al. | May 2004 | A1 |
| 20040116807 | Amrami et al. | Jun 2004 | A1 |
| 20040120557 | Sabol et al. | Jun 2004 | A1 |
| 20040122311 | Cosman | Jun 2004 | A1 |
| 20040125918 | Shanmugaval et al. | Jul 2004 | A1 |
| 20040138557 | Le et al. | Jul 2004 | A1 |
| 20040143449 | Behrenbruch et al. | Jul 2004 | A1 |
| 20040144925 | Stoddart et al. | Jul 2004 | A1 |
| 20040153128 | Suresh et al. | Aug 2004 | A1 |
| 20040162492 | Kobayashi | Aug 2004 | A1 |
| 20040171924 | Mire et al. | Sep 2004 | A1 |
| 20040183022 | Weinberg | Sep 2004 | A1 |
| 20040184644 | Leichter et al. | Sep 2004 | A1 |
| 20040193453 | Butterfield et al. | Sep 2004 | A1 |
| 20040195512 | Crosetto | Oct 2004 | A1 |
| 20040204646 | Nagler et al. | Oct 2004 | A1 |
| 20040205343 | Forth et al. | Oct 2004 | A1 |
| 20040210126 | Hajaj et al. | Oct 2004 | A1 |
| 20040238743 | Gravrand et al. | Dec 2004 | A1 |
| 20040251419 | Nelson et al. | Dec 2004 | A1 |
| 20040253177 | Elmaleh et al. | Dec 2004 | A1 |
| 20040258201 | Hayashida | Dec 2004 | A1 |
| 20040263865 | Pawlak et al. | Dec 2004 | A1 |
| 20050001170 | Juni | Jan 2005 | A1 |
| 20050006589 | Young et al. | Jan 2005 | A1 |
| 20050020898 | Vosniak et al. | Jan 2005 | A1 |
| 20050020915 | Bellardinelli et al. | Jan 2005 | A1 |
| 20050023474 | Persyk et al. | Feb 2005 | A1 |
| 20050029277 | Tachibana | Feb 2005 | A1 |
| 20050033157 | Klein et al. | Feb 2005 | A1 |
| 20050049487 | Johnson et al. | Mar 2005 | A1 |
| 20050055174 | David et al. | Mar 2005 | A1 |
| 20050056788 | Juni | Mar 2005 | A1 |
| 20050074402 | Cagnolini et al. | Apr 2005 | A1 |
| 20050107698 | Powers et al. | May 2005 | A1 |
| 20050107914 | Engleson et al. | May 2005 | A1 |
| 20050108044 | Koster | May 2005 | A1 |
| 20050113945 | Engleson et al. | May 2005 | A1 |
| 20050113960 | Karau et al. | May 2005 | A1 |
| 20050117029 | Shiomi | Jun 2005 | A1 |
| 20050121505 | Metz et al. | Jun 2005 | A1 |
| 20050131270 | Weil et al. | Jun 2005 | A1 |
| 20050145797 | Oaknin et al. | Jul 2005 | A1 |
| 20050148869 | Masuda | Jul 2005 | A1 |
| 20050149350 | Kerr et al. | Jul 2005 | A1 |
| 20050156115 | Kobayashi et al. | Jul 2005 | A1 |
| 20050173643 | Tumer | Aug 2005 | A1 |
| 20050187465 | Motomura et al. | Aug 2005 | A1 |
| 20050198800 | Reich | Sep 2005 | A1 |
| 20050203389 | Williams | Sep 2005 | A1 |
| 20050205792 | Rousso et al. | Sep 2005 | A1 |
| 20050205796 | Bryman | Sep 2005 | A1 |
| 20050207526 | Altman | Sep 2005 | A1 |
| 20050211909 | Smith | Sep 2005 | A1 |
| 20050215889 | Patterson, II | Sep 2005 | A1 |
| 20050234424 | Besing et al. | Oct 2005 | A1 |
| 20050247893 | Fu et al. | Nov 2005 | A1 |
| 20050253073 | Joram et al. | Nov 2005 | A1 |
| 20050261936 | Silverbrook et al. | Nov 2005 | A1 |
| 20050261937 | Silverbrook et al. | Nov 2005 | A1 |
| 20050261938 | Silverbrook et al. | Nov 2005 | A1 |
| 20050266074 | Zilberstein et al. | Dec 2005 | A1 |
| 20050277833 | Williams, Jr. | Dec 2005 | A1 |
| 20050277911 | Stewart et al. | Dec 2005 | A1 |
| 20050278066 | Graves et al. | Dec 2005 | A1 |
| 20050288869 | Kroll et al. | Dec 2005 | A1 |
| 20060000983 | Charron et al. | Jan 2006 | A1 |
| 20060033028 | Juni | Feb 2006 | A1 |
| 20060036157 | Tumer | Feb 2006 | A1 |
| 20060072799 | McLain | Apr 2006 | A1 |
| 20060074290 | Chen et al. | Apr 2006 | A1 |
| 20060104519 | Stoeckel et al. | May 2006 | A1 |
| 20060109950 | Arenson et al. | May 2006 | A1 |
| 20060122503 | Burbank et al. | Jun 2006 | A1 |
| 20060145081 | Hawman | Jul 2006 | A1 |
| 20060160157 | Zuckerman | Jul 2006 | A1 |
| 20060188136 | Ritt et al. | Aug 2006 | A1 |
| 20060214097 | Wang et al. | Sep 2006 | A1 |
| 20060237652 | Kimchy et al. | Oct 2006 | A1 |
| 20060257012 | Kaufman et al. | Nov 2006 | A1 |
| 20070081700 | Blumenfeld et al. | Apr 2007 | A1 |
| 20070116170 | De Man et al. | May 2007 | A1 |
| 20070133852 | Collins et al. | Jun 2007 | A1 |
| 20070156047 | Nagler et al. | Jul 2007 | A1 |
| 20070166227 | Liu et al. | Jul 2007 | A1 |
| 20070183582 | Baumann et al. | Aug 2007 | A1 |
| 20070189436 | Goto et al. | Aug 2007 | A1 |
| 20070194241 | Rousso et al. | Aug 2007 | A1 |
| 20070265230 | Rousso et al. | Nov 2007 | A1 |
| 20080001090 | Ben-Haim et al. | Jan 2008 | A1 |
| 20080029704 | Hefetz et al. | Feb 2008 | A1 |
| 20080033291 | Rousso et al. | Feb 2008 | A1 |
| 20080036882 | Uemura et al. | Feb 2008 | A1 |
| 20080039721 | Shai et al. | Feb 2008 | A1 |
| 20080042067 | Rousso et al. | Feb 2008 | A1 |
| 20080128626 | Rousso et al. | Jun 2008 | A1 |
| 20080137938 | Zahniser | Jun 2008 | A1 |
| 20080230702 | Rousso et al. | Sep 2008 | A1 |
| 20080230705 | Rousso et al. | Sep 2008 | A1 |
| 20080237482 | Shahar et al. | Oct 2008 | A1 |
| 20080260228 | Dichterman et al. | Oct 2008 | A1 |
| 20080260580 | Helle et al. | Oct 2008 | A1 |
| 20080260637 | Dickman | Oct 2008 | A1 |
| 20080277591 | Shahar et al. | Nov 2008 | A1 |
| 20090001273 | Hawman | Jan 2009 | A1 |
| 20090018412 | Schmitt | Jan 2009 | A1 |
| 20090078875 | Rousso et al. | Mar 2009 | A1 |
| 20090112086 | Melman | Apr 2009 | A1 |
| 20090152471 | Rousso et al. | Jun 2009 | A1 |
| 20090190807 | Rousso et al. | Jul 2009 | A1 |
| 20090201291 | Ziv et al. | Aug 2009 | A1 |
| 20090236532 | Frach et al. | Sep 2009 | A1 |
| 20090304582 | Rousso et al. | Dec 2009 | A1 |
| 20100006770 | Balakin | Jan 2010 | A1 |
| 20100021378 | Rousso et al. | Jan 2010 | A1 |
| 20100102242 | Burr et al. | Apr 2010 | A1 |
| 20100121184 | Dhawale et al. | May 2010 | A1 |
| 20100140483 | Rousso et al. | Jun 2010 | A1 |
| 20100202664 | Busch et al. | Aug 2010 | A1 |
| 20100245354 | Rousso et al. | Sep 2010 | A1 |
| 20120106820 | Rousso et al. | May 2012 | A1 |
| 20120172699 | Nagler et al. | Jul 2012 | A1 |
| 20120248320 | Wangerin et al. | Oct 2012 | A1 |
| 20120326034 | Sachs et al. | Dec 2012 | A1 |
| 20130051643 | Jackson et al. | Feb 2013 | A1 |
| 20130114792 | Zilberstein et al. | May 2013 | A1 |
| 20130308749 | Zilberstein et al. | Nov 2013 | A1 |
| 20140151563 | Rousso et al. | Jun 2014 | A1 |
| 20140163368 | Rousso et al. | Jun 2014 | A1 |
| 20140187927 | Nagler et al. | Jul 2014 | A1 |
| 20140193336 | Rousso et al. | Jul 2014 | A1 |
| 20140200447 | Rousso et al. | Jul 2014 | A1 |
| 20140249402 | Kimchy et al. | Sep 2014 | A1 |
| Number | Date | Country |
|---|---|---|
| 1516429 | Dec 1969 | DE |
| 19814199 | Oct 1999 | DE |
| 19815362 | Oct 1999 | DE |
| 0273257 | Jul 1988 | EP |
| 0525954 | Feb 1993 | EP |
| 0526970 | Feb 1993 | EP |
| 0543626 | May 1993 | EP |
| 0592093 | Apr 1994 | EP |
| 0697193 | Feb 1996 | EP |
| 0813692 | Dec 1997 | EP |
| 0887661 | Dec 1998 | EP |
| 1237013 | Sep 2002 | EP |
| 2031142 | Apr 1980 | GB |
| 59-141084 | Aug 1984 | JP |
| 61-026879 | Feb 1986 | JP |
| 01-324568 | Jun 1986 | JP |
| 03-121549 | May 1991 | JP |
| 04-151120 | May 1992 | JP |
| 06-109848 | Apr 1994 | JP |
| 07-059763 | Mar 1995 | JP |
| 07-141523 | Jun 1995 | JP |
| 08-292268 | Nov 1996 | JP |
| 10-260258 | Sep 1998 | JP |
| 11-072564 | Mar 1999 | JP |
| WO 9200402 | Jan 1992 | WO |
| WO 9816852 | Apr 1998 | WO |
| WO 9903003 | Jan 1999 | WO |
| WO 9930610 | Jun 1999 | WO |
| WO 9939650 | Aug 1999 | WO |
| WO 0010034 | Feb 2000 | WO |
| WO 0018294 | Apr 2000 | WO |
| WO 0022975 | Apr 2000 | WO |
| WO 0025268 | May 2000 | WO |
| WO 0031522 | Jun 2000 | WO |
| WO 0038197 | Jun 2000 | WO |
| WO 0189384 | Nov 2001 | WO |
| WO 0216965 | Feb 2002 | WO |
| WO 02058531 | Aug 2002 | WO |
| WO 02075357 | Sep 2002 | WO |
| WO 03073938 | Sep 2003 | WO |
| WO 03086170 | Oct 2003 | WO |
| WO 2004004787 | Jan 2004 | WO |
| WO 2004032151 | Apr 2004 | WO |
| WO 2004042546 | May 2004 | WO |
| WO 2004113951 | Dec 2004 | WO |
| WO 2005002971 | Jan 2005 | WO |
| WO 2005059592 | Jun 2005 | WO |
| WO 2005059840 | Jun 2005 | WO |
| WO 2005067383 | Jul 2005 | WO |
| WO 2005104939 | Nov 2005 | WO |
| WO 2005118659 | Dec 2005 | WO |
| WO 2005119025 | Dec 2005 | WO |
| WO 2006042077 | Apr 2006 | WO |
| WO 2006051531 | May 2006 | WO |
| WO 2006054296 | May 2006 | WO |
| WO 2006075333 | Jul 2006 | WO |
| WO 2006129301 | Dec 2006 | WO |
| WO 2007010534 | Jan 2007 | WO |
| WO 2007010537 | Jan 2007 | WO |
| WO 2007054935 | May 2007 | WO |
| WO 2007074467 | Jul 2007 | WO |
| WO 2008010227 | Jan 2008 | WO |
| WO 2008075362 | Jun 2008 | WO |
| Entry |
|---|
| Amendment After Allowance Under 37 CFR 1.312 Dated Sep. 13, 2010 to Notice of Allowance of Jul. 22, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/794,799. |
| Appeal Brief Dated Jan. 19, 2010 to Notice of Appeal of Nov. 16, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Communication Pursuant to Article 93(3) EPC Dated Mar. 8, 2010 From the European Patent Office Re.: Application No. 06832278.3. |
| Communication Pursuant to Article 94(3) EPC Dated Mar. 8, 2010 From the European Patent Office Re.: Application No. 06832278.3. |
| Communication Pursuant to Article 94(3) EPC Dated May 12, 2010 From the European Patent Office Re.: Application No. 06809851.6. |
| Communication Pursuant to Article 94(3) EPC Dated Apr. 16, 2010 From the European Patent Office Re. Application No. 01951883.6. |
| Communication Pursuant to Article 94(3) EPC Dated Oct. 21, 2009 From the European Patent Office Re.: Application No. 02716285.8. |
| Communication Pursuant to Article 94(3) EPC Dated Jul. 22, 2009 From the European Patent Office Re.: Application No. 06809851.6. |
| Communication Pursuant to Article 96(2) EPC Dated Jun. 19, 2006 From the European Patent Office Re.: Application No. 03810570.6. |
| Communication Pursuant to Article 96(2) EPC Dated Aug. 30, 2007 From the European Patent Office Re.: Application No. 03810570.6. |
| Communication Relating to the Results of the Partial International Search Dated Apr. 18, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2006/001291. |
| Communication Relating to the Results of the Partial International Search Dated May 21, 2008 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2007/001588. |
| International Preliminary Report on Patentability Dated Apr. 16, 2009 From the International Bureau of WIPO Re.: Application No. PCT/IL2007/000918. |
| International Preliminary Report on Patentability Dated Jun. 21, 2007 From the International Bureau of WIPO Re.: Application No. PCT/IL2005/000575. |
| International Preliminary Report on Patentability Dated Jan. 22, 2009 From the International Bureau of WIPO Re.: Application No. PCT/IL2006/000834. |
| International Preliminary Report on Patentability Dated Jan. 22, 2009 From the International Bureau of WIPO Re.: Application No. PCT/IL2006/001511. |
| International Preliminary Report on Patentability Dated May 22, 2007 From the International Preliminary Examining Authority Re.: Application No. PCT/IL06/00059. |
| International Preliminary Report on Patentability Dated May 22, 2008 From the International Bureau of WIPO Re.: Application No. PCT/IL2006/001291. |
| International Preliminary Report on Patentability Dated May 24, 2007 From the International Bureau of WIPO Re.: Application No. PCT/IL2005/001173. |
| International Preliminary Report on Patentability Dated Apr. 26, 2007 From the International Bureau of WIPO Re.: Application No. PCT/IL2005/000394. |
| International Preliminary Report on Patentability Dated Jan. 31, 2008 From the International Bureau of WIPO Re.: Application No. PCT/IL2006/000840. |
| International Search Report Dated Oct. 10, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/00059. |
| International Search Report Dated Jul. 11, 2008 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/01511. |
| International Search Report Dated Jul. 25, 2008 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2007/001588. |
| International Search Report Dated Feb. 1, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00048. |
| International Search Report Dated Jul. 1, 2008 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/00834. |
| International Search Report Dated Nov. 1, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/00840. |
| International Search Report Dated Jul. 2, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2006/001291. |
| International Search Report Dated Aug. 3, 2006 From the international Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/001173. |
| International Search Report Dated May 11, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/001215. |
| International Search Report Dated Sep. 11, 2002 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL01/00638. |
| International Search Report Dated Sep. 12, 2002 From the International Searching Authority of the Patent Cooperation Treaty Re: Application No. PCT/IL02/00057. |
| International Search Report Dated Oct. 15, 2008 From the International Searching Authority Re.: Application No. PCT/IL07/00918. |
| International Search Report Dated Mar. 18, 2004 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL03/00917. |
| International Search Report Dated Mar. 23, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00572. |
| International Search Report Dated May 24, 2007 From the International Searching Authority of Patent Cooperation Treaty Re.: Application No. PCT/IL05/00575. |
| International Search Report Dated Mar. 26, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00394. |
| Invitation to Pay Additional Fees Dated Jul. 10, 2008 From the International Searching Authority Re.: Application No. PCT/IL06/01511. |
| Invitation to Pay Additional Fees Dated Feb. 15, 2007 From the International Searching Authority Re.: Application No. PCT/IL05/00575. |
| Notice of Allowance Dated Jul. 16, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 12/084,559. |
| Notice of Allowance Dated Sep. 17, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/533,568. Suppl. IDS VIII in 25855. |
| Notice of Allowance Dated Jul. 22, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/794,799. |
| Notice of Allowance Dated Nov. 23, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 12/084,559. |
| Notice of Allowance Dated Aug. 25, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,617. |
| Notice of Allowance Dated Jun. 30, 2010 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 09/727,464. |
| Notice of Appeal and Pre-Appeal Brief Dated Jan. 4, 2010 to Official Action of Sep. 2, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Notice of Appeal Dated Nov. 16, 2009 to Official Action of Jul. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Office Action Dated Dec. 2, 2007 From the Israeli Patent Office Re.: Application No. 158442. |
| Office Action Dated Jan. 2, 2006 From the Israeli Patent Office Re.: Application No. 154323. |
| Office Action Dated Sep. 4, 2007 From the Israeli Patent Office Re.: Application No. 157007. |
| Office Action Dated Jul. 17, 2007 From the Israeli Patent Office Re.: Application No. 154323. |
| Official Action Dated Jun. 1, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/686,536. |
| Official Action Dated Mar. 1, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/794,799. |
| Official Action Dated Sep. 1, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/794,799. |
| Official Action Dated Jul. 2, 2004 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Mar. 2, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Mar. 2, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,617. |
| Official Action Dated Sep. 2, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Official Action Dated Aug. 3, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Official Action Dated May 3, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Official Action Dated Sep. 4, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/533,568. |
| Official Action Dated Sep. 5, 2002 From the US Patent and Trademark Office Re.: U.S. Appl. No. 12/084,559. |
| Official Action Dated Jan. 7, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Official Action Dated Jul. 7, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/533,568. |
| Official Action Dated Oct. 7, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Apr. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Official Action Dated Dec. 8, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/132,320. |
| Official Action Dated Jan. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Official Action Dated Apr. 9, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Official Action Dated Aug. 10, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Aug. 11, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Mar. 11, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Official Action Dated Jul. 12, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Dec. 13, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated May 13, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Official Action Dated May 14, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Official Action Dated Apr. 15, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Dec. 15, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Feb. 15, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Official Action Dated Jul. 15, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Jul. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Mar. 15, 2004 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/765,316. |
| Official Action Dated Sep. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Official Action Dated Sep. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Dec. 16, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Official Action Dated Sep. 16, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/727,464. |
| Official Action Dated Jan. 17, 2006 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 11/034,007. |
| Official Action Dated Jul. 19, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Official Action Dated Jul. 19, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Official Action Dated Mar. 19, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Official Action Dated Apr. 20, 2006 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Official Action Dated Jul. 20, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,617. |
| Official Action Dated Mar. 21, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/533,568. |
| Official Action Dated Sep. 21, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Official Action Dated Dec. 23, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/727,464. |
| Official Action Dated Feb. 23, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Jun. 23, 2006 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 09/727,464. |
| Official Action Dated Jun. 25, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Sep. 25, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Nov. 26, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Official Action Dated Jul. 27, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Official Action Dated Apr. 28, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Aug. 28, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Official Action Dated Apr. 29, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Official Action Dated Oct. 30, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Official Action Dated Sep. 30, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Sep. 30, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Response Dated Jul. 1, 2010 to Official Action of Mar. 2, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Response Dated Jul. 1, 2010 to Official Action of Mar. 2, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,617. |
| Response Dated Jun. 1, 2010 to Official Action of Mar. 1, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/794,799. |
| Response dated Sep. 1, 2010 to Official Action of Aug. 3, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Response Dated Jun. 3, 2010 to Notice of Appeal and Pre-Appeal Brief of Jan. 4, 2010 to Official Action of Sep. 2, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Response Dated Oct. 5, 2010 to Official Action of Jul. 19, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Response Dated Apr. 7, 2009 to Official Action of Oct. 7, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated Jul. 8, 2010 to Communication Pursuant to Article 94(3) EPC of Mar. 8, 2010 From the European Patent Office Re.: Application No. 06832278.3. |
| Response Dated Jul. 8, 2010 to Official Action of Apr. 9, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Response Dated Sep. 8, 2010 to Communication Pursuant to Article 94(3) EPC Dated May 12, 2010 From the European Patent Office Re.: Application No. 06809851.6. |
| Response Dated Dec. 10, 2009 to Official Action of Aug. 11, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Response Dated May 10, 2010 to Official Action of Apr. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Response Dated May 10, 2010 to Official Action of Jan. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Response Dated May 11, 2010 to Official Action of Mar. 11, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Response Dated Oct. 12, 2009 to Notice of Allowance of Jul. 16, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 12/084,559. |
| Response Dated Mar. 13, 2008 to Official Action of Dec. 13, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated Aug. 14, 2008 to Official Action of Apr. 15, 2008 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/727,464. |
| Response Dated Jan. 14, 2010 to Official Action of Sep. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. ,No. 10/616,307. |
| Response Dated Jan. 14, 2010 to Official Action of Sep. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Response Dated Oct. 14, 2009 to Official Action of May 14, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Response Dated Mar. 15, 2007 to Official Action of Dec. 15, 2006 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated Aug. 16, 2010 to Communication Pursuant to Article 94(3) EPC of Apr. 16, 2010 From the European Patent Office Re. Application No. 01951883.6. |
| Response Dated Jan. 21, 2010 to Official Action of Sep. 21, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Response Dated Feb. 22, 2010 to Communication Pursuant to Article 94(3) EPC of Oct. 21, 2009 From the European Patent Office Re.: Application No. 02716285.8. |
| Response Dated Sep. 22, 2008 to Official Action of Jun. 25, 2008 From US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated Jun. 23, 2010 to Official Action of Feb. 23, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Response Dated Aug. 25, 2010 to Official Action of Jul. 27, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Response Dated Nov. 25, 2005 to Office Action of May 13, 2005 From the Patent Office of the People's Republic of China Re.: Application No. 1817689.5. |
| Response Dated Jul. 26, 2010 to Official Action of Apr. 28, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated May 26, 2010 to Official Action of Mar. 19, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Response Dated Dec. 28, 2009 to Official Action of Aug. 28, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Response Dated Dec. 30, 2009 to Official Action of Sep. 1, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/794,799. |
| Response Dated Dec. 30, 2009 to Official Action of Oct. 30, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Response Dated Oct. 31, 2007 to Official Action of Jul. 12, 2007 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response to the International Search Report and the Written Opinion of Oct. 10, 2006 From the International Searching Authority Re.: Appliction No. PCT/IL06/00059. |
| Second International Search Report Dated Jun. 1, 2009 From the International Searching Authority Re.: Application No. PCT/IL07/00918. |
| Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC Dated Jan. 16, 2009 From the European Patent Office Re.: Application No. 03810570.6. |
| Supplemental Response After Interview Dated Aug. 4, 2010 to Official Action of Mar. 2, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,617. |
| Supplemental Response Under 37 C.F.R. § 1.125 Dated Aug. 12, 2010 to Telephonic Interview of Aug. 6, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,617. |
| Supplementary European Search Report Dated Dec. 12, 2005 From the European Patent Office Re.: Application No. 03810570.6. |
| Supplementary Partial European Search Report and the European Search Opinion Dated Dec. 15, 2009 From the European Patent Office Re.: Application No. 06832278.3. |
| Supplementary Partial European Search Report and the European Search Opinion Dated Oct. 16, 2009 From the European Patent Office Re.: Application No. 06756259.5. |
| Supplementary Partial European Search Report Dated Sep. 4, 2007 From the European Patent Office Re.: Application No. 0 2716285.8. |
| Supplementary Partial European Search Report Dated Nov. 11, 2008 From the European Patent Office Re.: Application No. 01951883.6. |
| Supplementary Partial European Search Report Dated Nov. 20, 2007 From the European Patent Office Re.: Application No. 02716285.8. |
| Translation of Office Action Dated May 13, 2005 From the Patent Office of the People's Republic of China Re.: Application No. 01817689.5. |
| Written Opinion Dated Feb. 1, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00048. |
| Written Opinion Dated Jul. 1, 2008 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/00834. |
| Written Opinion Dated Jul. 2, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL2006/001291. |
| Written Opinion Dated Aug. 3, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/001173. |
| Written Opinion Dated Oct. 10, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/00059. |
| Written Opinion Dated Oct. 15, 2008 From the International Searching Authority Re.: Application No. PCT/IL07/00918. |
| Written Opinion Dated Mar. 23, 2006 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00572. |
| Written Opinion Dated May 24, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00575. |
| Written Opinion Dated Jul. 25, 2008 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/001173. |
| Written Opinion Dated Mar. 26, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00394. |
| Aoi et al. “Absolute Quantitation of Regional Myocardial Blood Flow of Rats Using Dynamic Pinhole SPECT”, IEEE Nuclear Science Symposium and Medical Imaging Conference Record, 3: 1780-1783, 2002. Abstract, Figs. |
| Beekman et al. “Efficient Fully 3-D iterative SPECT Reconstruction With Monte Carlo-Based Scatter Compensation”, IEEE Transactions on Medical Imaging, 21(8): 867-877, Aug. 2002. |
| Bloch et al. “Application of Computerized Tomography to Radiation Therapy and Surgical Planning”, Proceedings of the IEEE, 71(3): 351-355, Mar. 1983. |
| Bromiley et al. “Attenuation Correction in PET Using Consistency Conditions and a Three-Dimensional Template”, IEEE Transactions on Nuclear Science, XP002352920, 48(4): 1371-1377, 2001. p. 1376, col. 2, § 2. |
| Brown et al. “Method for Segmenting Chest CT Image Data Using an Anatomical Model: Preliminary Results”, IEEE Transactions on Medical Imaging, 16(6): 828-839, Dec. 1997. |
| Corstens et al. “Nuclear Medicine's Role in Infection and Inflammation”, The Lancet, 354: 765-770, 1999. |
| Day et al. “Localization of Radioiodinated Rat Fibrogen in Transplanted Rat Tumors”, Journal of the National Cancer Institute, 23(4): 799-812, 1959. |
| Del Guerra et al. “An Integrated PET-SPECT Small Animal Imager: Preliminary Results”, Nuclear Science Symposium, IEEE Records, 1: 541-544, 1999. |
| Erbil et al. “Use and Limitations of Serum Total and Lipid-Bound Sialic Acid Concentrations as Markers for Colorectal Cancer”, Cancer, 55: 404-409, 1985. |
| Garcia et al. “Accuracy of Dynamic SPECT Acquisition for Tc-99m Teboroxime Myocardial Perfusion Imaging: Preliminary Results”, American College of Cardiology, 51st Annual Scientific Session, Atlanta, Georgia, USA, 8 P., 2002. |
| Gilland et al. “A 3D Model of Non-Uniform Attenuation and Detector Response for Efficient Iterative Reconstruction in SPECT”, Physics in Medicine and Biology, XP002558623, 39(3): 547-561, Mar. 1994. p. 549-550, Section 2.3 ‘Active Voxel Reconstruction’, p. 551, Lines 4-8. |
| Gilland et al. “Simultaneous Reconstruction and Motion Estimation for Gated Cardiac ECT”, IEEE Transactions on Nuclear Science, XP011077797, 49(5): 2344-2349, Oct. 1, 2002. p. 2344, Section ‘Introduction’, First §. |
| Gugnin et al “Radiocapsule for Recording the Ionizing Radiation in the Gastrointestinal Tract”, UDC 615. 417:616.34-005.1-073.916-71 (All-Union Scientific-Research Institute of medical Instrument Design, Moscow. Translated from Meditsinskaya Tekhnika, 1:21-25, Jan.-Feb. 1972). |
| Hassan et al. “A Radiotelemetry Pill for the Measurement of Ionising Radiation Using a Mercuric Iodide Detector”, Physics in Medicine and Biology, 23(2): 302-308, 1978. |
| Hayakawa et al. “A PET-MRI Registration Technique for PET Studies of the Rat Brain”, Nuclear Medicine & Biology, 27: 121-125, 2000. p. 121, col. 1. |
| Hoffman et al. “Intraoperative Probes and Imaging Probes”, European Journal of Nuclear Medicine, 26(8): 913-935, 1999. |
| Huesman et al. “Kinetic Parameter Estimation From SPECT Cone-Beam Projection Measurements”, Physics in Medicine and Biology, 43(4): 973-982, 1998. |
| Jeanguillaume et al. “From the Whole-Body Counting to Imaging: The Computer Aided Collimation Gamma Camera Project (CACAO)”, Radiation Projection Dosimetry 89(3-4): 349-352, 2000. |
| Jessup “Tumor Markers—Prognostic and Therapeutic Implications for Colorectal Carcinoma”, Surgical Oncology, 7: 139-151, 1998. |
| Kadrmas et al. “Static Versus Dynamic Teboroxime Myocardial Perfusion SPECT in Canines”, IEEE Transactions on Nuclear Sicence, 47(3): 1112-1117, Jun. 2000. |
| Kinahan et al. “Attenuation Correction for a Combined 3D PET/CT Scanner”, Medical Physics, 25(10): 2046-2053, Oct. 1998. |
| Kojima et al. “Quantitative Planar Imaging Method for Measurement of Renal Activity by Using a Conjugate-Emission Image and Transmission Data”, Medical Physics, 27(3): 608-615, 2000. p. 608. |
| Lavallée et al. “Building a Hybrid Patient's Model for Augmented Reality in Surgery: A Registration Problem”, Computing in Biological Medicine, 25(2): 149-164, 1995. |
| Li et al. “A HOTLink/Networked PC Data Acquisition and Image Reconstruction System for a High Resolution Whole-Body PET With Respiratory or ECG-Gated Performance”, IEEE Nuclear Sience Symposium and Medical Imaging Conference, Norfolk, VA, USA, Nov. 10-16, 2002, XP010663724, 2: 1135-1139, Nov. 10, 2002. p. 1137, First Col., 2nd §. |
| Molinolo et al. “Enhanced Tumor Binding Using Immunohistochemical Analyses by Second Generation Anti-Tumor-Associated Glycoprotein 72 Monoclonal Antibodies versus Monoclonal Antibody B72.3 in Human Tissue”, Cancer Research, 50: 1291-1298, 1990. |
| Moore et al. “Quantitative Multi-Detector Emission Computerized Tomography Using Iterative Attenuation Compensation”, Journal of Nuclear Medicine, XP002549083, 23(8): 706-714, Aug. 1982. Abstract, p. 707, Section ‘The Multi-Detector Scanner’, First §. |
| Mori et al. “Overexpression of Matrix Metalloproteinase-7mRNA in Human Colon Carcinomas”, Cancer, 75: 1516-1519, 1995. |
| Ogawa et al. “Ultra High Resoultion Pinhole SPECT”, IEEE Nuclear Science Symposium, 2: 1600-1604, 1998. |
| Pardridge et al. “Tracer Kinetic Model of Blood-Brain Barrier Transport of Plasma Protein-Bound Ligands”, Journal of Clinical Investigation, 74: 745-752, 1984. Suppl. IDS in 27480. |
| Pellegrini et al. “Design of Compact Pinhole SPECT System Based on Flat Panel PMT”, IEEE Nuclear Science Symposium Conference Record, 3: 1828-1832, 2003. |
| Piperno et al. “Breast Cancer Screening by Impedance Measurements”, Frontiers Med. Biol. Engng., 2(2): 11-17, 1990. |
| Qi et al. “Resolution and Noise Properties of MAP Reconstruction for Fully 3-D PET”, IEEE Transactions on Medical Imaging, XP002549082, 19(5): 493-506, May 2000. p. 493, col. 2, Lines 10-21, p. 495, col. 1, Last §. |
| Quartuccia et al. “Computer Assisted Collimation Gama Camera: A New Approach to Imaging Contaminated Tissues”, Radiation Projection Dosimetry, 89(3-4): 343-348, 2000. |
| Rajshekhar “Continuous Impedence Monitoring During CT-Guided Stereotactic Surgery: Relative Value in Cystic and Solid Lesions”, British Journal of Neurosurgery, 6: 439-444, 1992. |
| Reutter et al. “Direct Least Squares Estimation of Spatiotemporal Distributions From Dynamic SPECT Projections Using a Spatial Segmentation and Temporal B-Splines”, IEEE Transactions on Medical Imaging, 19(5): 434-450, 2000. |
| Reutter et al. “Kinetic Parameter Estimation From Attenuated SPECT Projection Measurements”, IEEE Transactions on Nuclear Science, 45(6): 3007-3013, 1998. |
| Stoddart et al. “New Multi-Dimensional Reconstructions for the 12-Detector, Scanned Focal Point, Single-Photon Tomograph”, Physics in Medicine and Biology, XP020021960, 37(3): 579-586, Mar. 1, 1992. p. 582, § 2—p. 585, § 1. |
| Takahashi et al. “Attenuation Correction of Myocardial SPECT Images With X-Ray CT: Effects of Registration Errors Between X-Ray CT and SPECT”, Annals of Nuclear Medicine, 16(6): 431-435, Sep. 2002. |
| Wilson et al. “Non-Stationary Noise Characteristics for SPECT Images”, Proceedings of the Nuclear Science Symposium and Medical Imaging Conference, Santa Fe, CA, USA, Nov. 2-9, 1991, XP010058168, p. 1736-1740, Nov. 2, 1991. p. 1736, col. 2, Lines 4-6. |
| Wu et al. “ECG-Gated Pinhole SPECT in Mice With Millimeter Spatial Resolution”, IEEE Transactions on Nuclear Science, 47(3): 1218-1221, Jun. 2000. |
| Yu et al. “Using Correlated CT Images in Compensation for Attenuation in PET Image Reconstruction”, Proceedings of the SPIE, Applications of Optical Engineering: Proceedings of OE/Midwest '90, 1396: 56-58, 1991. |
| Zaidi et al. “Magenetic Resonance Imaging-Guided Attenuation and Scatter Corrections in Three-Dimensional Brain Positron Emission Tomography”, Medical Physics, 30(5): 937-948, May 2003. |
| Zaidi et al. “MRI-Guided Attenuation Correction in 3D Brain PET”, Neuroimage Human Brain Mapping 2002 Meeting, 16(2): Abstract 504, Jun. 2002. |
| Zhang et al. “An Innovative High Efficiency and High Resolution Probe for Prostate Imaging”, The Journal of Nuclear Medicine, 68: 18, 2000. Abstract. |
| Official Action Dated Dec. 15, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Official Action Dated Dec. 20, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/309,479. |
| Response Dated Nov. 13, 2011 to Official Action of Sep. 12, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Response Dated Dec. 29, 2011 to Office Action of Jul. 17, 2007 From the Israeli Patent Office Re.: Application No. 154323. |
| Berman et al. “Dual-Isotope Myocardial Perfusion SPECT With Rest Thallium-201 and Stress Tc-99m Sestamibi”, Cardiology Clinics, 12(2): 261-270, May 1994. |
| DeGrado et al. “Topics in Integrated Systems Physiology. Tracer Kinetic Modeling in Nuclear Cardiology”, Journal of Nuclear Cardiology, 7: 686-700, 2000. |
| Links “Advances in SPECT and PET Imaging”, Annals in Nuclear Medical Science, 13(2): 107-120, Jun. 2000. |
| Official Action Dated Dec. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Official Action Dated Nov. 10, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Official Action Dated Nov. 10, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Nov. 23, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Response Dated Nov. 18, 2010 to Official Action of Jul. 19, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Notice of Allowance Dated Dec. 17, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,617. |
| Official Action Dated Dec. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Dec. 28, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Response Dated Dec. 15, 2010 to Official Action of Jul. 19, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Official Action Dated Oct. 7, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/750,057. |
| Official Action Dated Oct. 7, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/932,872. |
| Official Action Dated Jan. 19, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Official Action Dated Jan. 23, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Jin et al. “Reconstruction of Cardiac-Gated Dynamic SPECT Images”, IEEE International Conference on Image Processing 2005, ICIP 2005, Sep. 11-14, 2005, 3: 1-4, 2005. |
| Toennies et al. “Scatter Segmentation in Dynamic SPECT Images Using Principal Component Analysis”, Progress in Biomedical Optics and Imaging, 4(23): 507-516, 2003. |
| Communication Pursuant to Article 94(3) EPC Dated Sep. 23, 2011 From the European Patent Office Re.: Application No. 06832278.3. |
| Written Opinion Dated Nov. 1, 2007 from the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/00840. |
| Written Opinion Dated Jul. 11, 2008 from the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL06/01511. |
| Official Action Dated Jan. 31, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Official Action Dated Jan. 28, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Response Dated Feb. 10, 2011 to Official Action of Nov. 10, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Response Dated Jan. 27, 2011 to Official Action of Nov. 1, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Response Dated Jan. 31, 2011 to Official Action of Sep. 30, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Notice of Allowance Dated Feb. 2, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/628,074. |
| Communication Pursuant to Article 94(3) EPC Dated Mar. 2, 2011 From the European Patent Office Re.: Application No. 06756259.5. |
| Notice of Allowance Dated Nov. 15, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 10/616,301. |
| Notice of Non-Compliant Amendment Dated Feb. 14, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Response Dated Feb. 10, 2011 to Notice of Allowance of Nov. 15, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 10/616,301. |
| Mettler et al. “Legal Requirements and Radiation Safely”, Essentials of Nuclear Medicine Imaging, 2nd Ed., Chap.13: 323-331, 1985. |
| Notice of Panel Decision From Pre-Appeal Brief Review Dated Feb. 29, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Mar. 1, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Official Action Dated Dec. 22, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/514,785. |
| Official Action Dated Feb. 28, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| International Search Report Dated May 24, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00575. |
| Response Dated Mar. 8, 2011 to Official Action of Dec. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Lavall?e et al. “Building a Hybrid Patient's Model for Augmented Reality in Surgery: A Registration Problem”, Computing in Biological Medicine, 25(2): 149-164, 1995. |
| Lin et al. “Improved Sensor Pills for Physiological Monitoring”, NASA Technical Brief, JPL New Technology Report, NPO-20652, 25(2), 2000. |
| Mettler et al. “Legal Requirements and Radiation Safety”, Essentials of Nuclear Medicine Imaging, 2nd Ed., Chap.13: 323-331, 1985. |
| Notice of Allowance Dated Feb. 23, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Official Action Dated Mar. 15, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Response Dated Mar. 24, 2011 to Official Action of Dec. 8, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Mar. 6, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/792,856. |
| Restriction Official Action Dated Mar. 9, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/976,852. |
| Office Action Dated Jul. 17, 2007 From the Israeli Patent Office Re.: Application No. 154323 and Its Translation Into English. |
| Communication Pursuant to Rules 70(2) and 70a(2) EPC Dated Apr. 4, 2011 From the European Patent Office Re. Application No. 05803689.8. |
| Response Dated Mar. 31, 2011 to Official Action of Jan. 31, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Response Dated Apr. 5, 2011 to Official Action of Nov. 10, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Supplementary European Search Report and the European Search Opinion Dated Mar. 16, 2011 From the European Patent Office Re. Application No. 05803689.8. |
| Hermann et al. “Mitochondrial Proteome: Altered Cytochtrome C Oxidase Subunit Levels in Prostate Cancer”, Proteomics, XP002625778, 3(9): 1801-1810, Sep. 2003. |
| Krieg et al. “Mitochondrial Proteome: Cancer-Altered Metabolism Associated With Cytochrome C Oxidase Subunit Level Variation”, Proteomics, XP002625779, 4(9): 2789-2795, Sep. 2004. |
| Interview Summary Dated Mar. 25, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Mao et al. “Human Prostatic Carcinoma: An Electron Microscope Study”, Cancer Research, XP002625777, 26(5): 955-973, May 1966. |
| Storey et al. “TC-99m Sestamibi Uptake in Metastatic Prostate Carcinoma”, Clinical Nuclear Medicine, XP009145398, 25(2): 133-134, Feb. 2000. |
| Restriction Official Action Dated Apr. 13, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/989,223. |
| Response Dated Mar. 3, 2011 to Notice of Non-Compliant Amendment of Feb. 14, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Response Dated Jan. 14, 2010 to Official Action of Sep. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Kadrmas et al. “Static Versus Dynamic Teboroxime Myocardial Perfusion SPECT in Canines”, IEEE Transactions on Nuclear Science, 47(3): 1112-1117, Jun. 2000. |
| International Preliminary Report on Patentability Dated Apr. 16, 2009 From the International Bureau of WIPO Re.: Applicaiton No. PCT/IL2007/000918. |
| International Search Report May 24, 2007 From the International Searching Authority of the Patent Cooperation Treaty Re.: Application No. PCT/IL05/00575. |
| Invitation to Pay Additional Fees Dated Feb. 15, 2007, From the International Searching Authority Re.: Application No. PCT/IL05/00575. |
| Office Action Dated Sep. 4, 2007, From the Israeli Patent Office Re.: Application No. 157007. |
| Official Action Dated Jun. 1, 2006, From the United States Patent and Trademark Office Re.: U.S. Appl. No. 10/686,536. |
| Official Action Dated May 3, 2007 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Official Action Dated Sep. 5, 2002 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 12/084,559. |
| Official Action Dated Oct. 7, 2008 From the US Patent Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Aug. 10, 2007 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Apr. 15, 2008 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Dec. 15, 2006 From the US Patent Office Re.: U.S. Appl. No. 10/616,301. |
| Official Action Dated Feb. 15, 2008 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Official Action Dated Jul. 15, 2008 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Mar. 15, 2004 From the United States Patent and Trademark Office Re.: U.S. Appl. No. 09/725,316. |
| Second Written Opinion Dated Jun. 1, 2009 From the International Searching Authority Re.: Application No. PCT/IL07/00918. |
| Stoddart et al. “New Multi-Dimensional Reconstructions for the 12-Detector, Scanned Focal Point, Single-Photon Tomograph”, Physics in Medicine and Biology, XP020021960, 37(3): 579-586, Mar. 1, 1992. p. 582, § 2-p. 585, § 1. |
| Notice of Allowance Dated Sep. 17, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/533,568. |
| Response Dated Nov. 16, 2009 to Official Action of Jul. 15, 2009 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated Apr. 18, 2010 to Official Action of Feb. 17, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/702,154. |
| Official Action Dated Apr. 16, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Notice of Allowance Dated May 5, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/240,239. |
| Notice of Allowance Dated May 6, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,617. |
| Official Action Dated Apr. 20, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Official Action Dated Apr. 27, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Communication Pursuant to Article 94(3) EPC Dated May 12, 2010 From the European Patent Office Re. Application No. 06809851.6. |
| International Preliminary Report on Patentability Dated Apr. 7, 2009 From the International Bureau of WIPO Re. Application No. PCT/IL2007/000918. |
| International Preliminary Report on Patentability Dated Jan. 13, 2009 From the International Bureau of WIPO Re. Application No. PCT/IL2006/000834. |
| International Preliminary Report on Patentability Dated May 14, 2008 From the International Bureau of WIPO Re. Application No. PCT/IL2006/001291. |
| International Preliminary Report on Patentability Dated May 15, 2007 From the International Bureau of WIPO Re. Application No. PCT/IL2005/001173. |
| International Search Report Dated Jul. 1, 2008 From the International Searching Authority Re. Application No. PCT/IL2006/000834. |
| International Search Report Dated Jul. 2, 2007 From the International Searching Authority Re. Application No. PCT/IL2006/001291. |
| International Search Report Dated Aug. 3, 2006 From the International Searching Authority Re. Application No. PCT/IL2005/001173. |
| International Search Report Dated Oct. 15, 2008 From the International Searching Authority Re. Application No. PCT/2007/000918. |
| Official Action Dated Nov. 1, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/728,383. |
| Official Action Dated Mar. 2, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,617. |
| Official Action Dated Dec. 8, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,690. |
| Official Action Dated Apr. 9, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/798,017. |
| Official Action Dated Aug. 13, 2008 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/769,826. |
| Official Action Dated Feb. 16, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/747,378. |
| Official Action Dated May 18, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/989,223. |
| Official Action Dated Apr. 20, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/798,017. |
| Official Action Dated Sep. 21, 2009 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/798,017. |
| Official Action Dated May 23, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,690. |
| Official Action Dated Sep. 30, 2010 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/798,017. |
| Bracco Diagnostics “Cardiotec®: Kit for the Preparation of Technetium Tc 99m Teboroxime. For Diagnostic Use”, Bracco Diagnostics Inc., Product Sheet, 2 P., Jul. 2003. |
| Bracco Diagnostics “Techneplex®: Kit for the Preparation of Technetium Tc 99m Pentetate Injection. Diagnostic—for Intravenous Use”, Bracco Diagnostics™, Product Sheet, 5 P., Jun. 1995. |
| Dewaraja et al. “Accurate Dosimetry in 1311 Radionuclide Therapy Using Patient-Specific, 3-Dimensional Methods for SPECT Reconstruction and Basorbed Dose Calculation”, The Journal of Nuclear Medicine, 46(5): 840-849, May 2005. |
| GE Healthcare “Myoview™: Kit for the Preparation of Technetium Tc99m Tetrofosmin for Injection. Diagnostic Radiopharmaceutical. For Intravenous Use Only. Rx Only”, GE Healthcare, Product Sheet, 4 P., Aug. 2006. |
| Mallinckrodt “Kit for the Preparation of Technetium Tc 99m Sestamibi Injection”, Mallinckrodt Inc., Product Sheet, 2 P., Sep. 8, 2008. |
| Mallinckrodt “OctreoScan®: Kit for the Preparation of Indium In-111 Pentetreotide. Diagnostic—for Intravenous Use. Rx Only”, Mallinckrodt Inc., Product Sheet, 2 P., Oct. 25, 2006. |
| Pharmalucence “Kit for the Preparation of Technetium Tc99m Sulfur Colloid Injection for Subcutaneous, Intraperitoneal, Intravenous, and Oral Use”, Pharmalucence Inc., Reference ID: 2977567, Prescribing Information, 10 P., Jul. 2011. |
| Saltz et al. “Interim Report of Randomized Phase II Trial of Cetuximab/Bevacizumab/Irinotecan (CBI) Versus Cetuximab/Bevacizumab (CB) in Irinotecan-Refractory Colorectal Cancer”, Gastrointestinal Cancer Symposium, Hollywood, FL, USA, Jan. 27-29, 2005, American Society of Clinical Oncology, Abstract 169b, 4P., 2005. |
| Trikha et al. “Monoclonal Antibodies as Therapeutics in Oncology”, Current Opinion in Biotechnology, 13: 609-614, 2002. |
| Volkow et al. “Imaging the Living Human Brain: Magnetic Resonance Imaging and Positron Emission Tomography”, Proc. Natl. Acad. Sci. USA, 94: 2787-2788, Apr. 1997. |
| Official Action Dated May 23, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Official Action Dated May 23, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Official Action Dated May 23, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Chengazi et al. “Imaging Prostate Cancer With Technetium-99m-7E11-C5.3 (CYT-351)”, Journal of Nuclear Medicine, 38: 675-682, 1997. |
| McJilton et al. “Protein Kinase Cε Interacts With Bax and Promotes Survival of Human Prostate Cancer Cells”, Oncogene, 22; 7958-7968, 2003. |
| Xu et al. “Quantitative Expression Profile of Androgen-Regulated Genes in Prostate Cancer Cells and Identification of Prostate-Specific Genes”, International Journal of Cancer, 92: 322-328, 2001. |
| Communication Pursuant to Article 94(3) EPC Dated May 29, 2012 From the European Patent Office Re. Application No. 05803689.8. |
| Communication Under Rule 71(3) EPC Dated May 30, 2012 From the European Patent Office Re.: Application No. 02716285.8. |
| Interview Summary Dated May 31, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 10/616,301. |
| Communication Pursuant to Article 94(3) EPC Dated Jun. 11, 2012 From the European Patent Office Re.: Application No. 06756259.5. |
| Dillman “Radiolabeled Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoma”, Journal of Clinical Oncology, 20(16): 3545-3557, Aug. 15, 2002. |
| Sands et al. “Methods for the Study of the Metabolism of Radiolabeled Monoclonal Antibodies by Liver and Tumor”, The Journal of Nuclear Medicine, 28: 390-398, 1987. |
| Official Action Dated Jun. 21, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/309,479. |
| Notice of Allowance Dated Jun. 23, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Advisory Action Before the Filing of an Appeal Brief Dated Jul. 12, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Official Action Dated May 18, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/514,785. |
| Official Action Dated Apr. 19, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/750,057. |
| Official Action Dated Apr. 23, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/932,987. |
| Official Action Dated Jun. 28, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/628,074. |
| Examination Report Dated Jun. 22, 2011 From the Government of India, Patent Office, Intellectual Property Building Re. Application No. 2963/CHENP/2006. |
| Official Action Dated Mar. 9, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated Jun. 7, 2011 to Official Action of Mar. 9, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,301. |
| Response Dated Jun. 28, 2011 to Official Action of Dec. 28, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Official Action Dated Jul. 11, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,683. |
| Response Dated Jul. 14, 2011 to Official Action of Mar. 15, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Official Action Dated Jul. 12, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Official Action Dated Jul. 30, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,683. |
| Bowsher et al. “Treatment of Compton Scattering in Maximum-Likelihood, Expectation-Maximization Reconstructions of SPECT Images”, Journal of Nuclear Medicine, 32(6): 1285-1291, 1991. |
| Official Action Dated Aug. 2, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Handrick et al. “Evaluation of Binning Strategies for Tissue Classification in Computed Tomography Images”, Medical Imaging 2006: Image Processing, Proceedings of the SPIE, 6144: 1476-1486, 2006. |
| Thorndyke et al. “Reducing Respiratory Motion Artifacts in Positron Emission Tomography Through Retrospective Stacking”, Medical Physics, 33(7): 2632-2641, Jul. 2006. |
| Response Dated Sep. 1, 2011 to Communication Pursuant to Article 94(3) EPC of Mar. 2, 2011 From the European Patent Office Re.: Application No. 06756259.5. |
| Response Dated Aug. 29, 2011 to Official Action of Apr. 27, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Aug. 31, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Official Action Dated Sep. 12, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Official Action Dated Sep. 12, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Response Dated Sep. 12, 2011 to Official Action of Jul. 11, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,683. |
| Response Dated Sep. 20, 2011 to Official Action of Apr. 20, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Communication Pursuant to Article 94(3) EPC Dated Sep. 22, 2011 From the European Patent Office Re. Application No. 06756258.7. |
| Notice of Allowance Dated Sep. 16, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Official Action Dated Sep. 13, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/976,852. |
| Ellestad “Stress Testing: Principles and Practice”, XP008143015, 5th Edition, p. 432, Jan. 1, 2003. |
| Gilland et al. “Long Focal Length, Asymmetric Fan Beam Collimation for Transmission Acquisition With a Triple Camera SPECT System”, IEEE Transactions on Nuclear Science, XP011087666, 44(3): 1191-1196, Jun. 1, 1997. |
| Meyers et al. “Age, Perfusion Test Results and Dipyridamole Reaction”, Radiologic Technology, XP008142909, 73(5): 409-414, May 1, 2002. |
| Zhang et al. “Potential of a Compton Camera for High Performance Scintimammography”, Physics in Medicine and Biology, XP020024019, 49(4): 617-638, Feb. 21, 2004. |
| Communication Pursuant to Article 94(3) EPC Dated Sep. 17, 2012 From the European Patent Office Re. Application No. 06832278.3. |
| Ouyang et al. “Incorporation of Correlated Structural Images in PET Image Reconstruction”, IEEE Transactions of Medical Imaging, 13(4): 627-640, Dec. 1994. |
| Notice of Allowance Dated Sep. 28, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/792,856. |
| Cancer Medicine “Radiolabeled Monoclonal Antibodies. Historical Perspective”, Cancer Medicine, 5th Ed., Sec.16: Principles of Biotherapeutics, Chap.65: Monoclonal Serotherapy, 2000. |
| Lange et al. “EM Reconstruction Algorithms for Emission and Transmission Tomography”, Journal of Computer Assisted Tomography, 8(2): 306-316, Apr. 1984. |
| Ohrvall et al. “Intraoperative Gamma Detection Reveals Abdominal EndocrineTumors More Efficiently Than Somatostatin Receptor Scintigraphy”, 6th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer, Cancer, 80: 2490-2494, 1997. |
| Rockmore et al. “A Maximum Likelihood Approach to Emission Image Reconstruction From Projections”, IEEE Transactions on Nuclear Science, 23(4): 1428-1432, Aug. 1976. |
| Shepp et al. “Maximum Likelihood Reconstruction for Emission Tomography”, IEEE Transactions on Medical Imaging, MI-1: 113-122, Oct. 1982. |
| Sitek et al. “Reconstruction of Dynamic Renal Tomographic Data Acquired by Slow Rotation”, The Journal of Nuclear Medicine, 42(11): 1704-1712, Nov. 2001. |
| Solanki “The Use of Automation in Radiopharmacy”, Hospital Pharmacist, 7(4): 94-98, Apr. 2000. |
| Weldon et al. “Quantification of Inflammatory Bowel Disease Activity Using Technetium-99m HMPAO Labelled Leucocyte Single Photon Emission Computerised Tomography (SPECT)”, Gut, 36: 243-250, 1995. |
| Response Dated Oct. 14, 2011 to Supplementary European Search Report and the European Search Opinion of Mar. 16, 2011 From the European Patent Office Re. Application No. 05803689.8. |
| Official Action Dated Oct. 11, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/976,852. |
| Official Action Dated Oct. 26, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/836,223. |
| Official Action Dated Oct. 27, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Supplemental Notice of Allowability Dated Oct. 24, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/607,075. |
| Official Action Dated Oct. 10, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/798,017. |
| Communication Pursuant to Article 94(3) EPC Dated Oct. 26, 2012 From the European Patent Office Re. Application No. 05803689.8. |
| Notice of Allowance Dated Oct. 11, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/988,926. |
| Response Dated Oct. 14, 2011 to Communication Pursuant to Rules 70(2) and 70a(2) EPC of Apr. 4, 2011 From the European Patent Office Re. Application No. 05803689.8. |
| Restriction Official Action Dated Nov. 8, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/309,479. |
| Communication Pursuant to Article 94(3) EPC Dated Nov. 12, 2012 From the European Patent Office Re. Application No. 06756258.7. |
| Notice of Allowance Dated Nov. 15, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,683. |
| Response Dated Nov. 14, 2011 to Official Action of Sep. 12, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Response Dated Oct. 24, 2011 to Official Action of May 23, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Restriction Official Action Dated Nov. 15, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,683. |
| Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC Dated Nov. 29, 2012 From the European Patent Office Re. Application No. 06756259.5. |
| Communication Pursuant to Article 94(3) EPC Dated Nov. 18, 2011 From the European Patent Office Re. Application No. 05803689.8. |
| Response Dated Nov. 14, 2011 to Official Action of Jul. 12, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Response Dated Nov. 23, 2011 to Official Action of May 23, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Response Dated Nov. 23, 2011 to Official Action of May 23, 2011 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Response Dated Nov. 28, 2011 to Official Action of Jun. 28, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/628,074. |
| Official Action Dated Nov. 1, 2010 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Pluim et al. “Image Registration by Maximization of Combined Mutual Information and Gradient Information”, IEEE Transactions on Medical Imaging, 19(8): 1-6, 2000. |
| Response Dated Dec. 8, 2011 to Restriction Official Action of Nov. 8, 2011 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/309,479. |
| Official Action Dated Mar. 11, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/345,719. |
| Official Action Dated Jun. 12, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Bacharach et al. “Attenuation Correction in Cardiac Positron Emission Tomography and Single-Photon Emission Computed Tomography”, Journal of Nucelar Cardiology, 2(3): 246-255, 1995. |
| Uni Magdeburg “Attenuation Map”, University of Magdeburg, Germany, Retrieved From the Internet, Archived on Jul. 31, 2002. |
| Zaidi et al. “Determination of the Attenuation Map in Emission Tomography”, Journal of Nuclear Medicine, 44(2): 291-315, 2003. |
| Notice of Allowance Dated Jun. 14, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 10/616,307. |
| Notice of Allowance Dated Jul. 19, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/989,223. |
| Notice of Allowance Dated Jul. 25, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/345,719. |
| Supplementary European Search Report and the European Search Opinion Dated Nov. 13, 2012 From the European Patent Office Re. Application No. 06728347.3. |
| Notice of Allowance Dated Mar. 14, 2013 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Studen “Compton Camera With Position-Sensitive Silicon Detectors”, Doctoral Thesis, University of Ljubljana, Faculty of Mathematics and Physics, 36 P. |
| Notice of Allowance Dated Apr. 10, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/976,852. |
| Applicant-Initiated Interview Summary Dated May 1, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 10/343,792. |
| Applicant-Initiated Interview Summary Dated May 1, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Notice of Allowance Dated Jun. 21, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Advisory Action before the Filing of an Appeal Brief Dated May 21, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Notice of Allowance Dated Jul. 15, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/932,987. |
| Official Action Dated Jul. 5, 2013 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/656,548. |
| Advisory Action Before the Filing of an Appeal Brief Dated Feb. 26, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/989,223. |
| Official Action Dated Nov. 30, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/989,223. |
| Notice of Allowance Dated Oct. 26, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/514,785. |
| Official Action Dated Nov. 30, 2012 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/514,785. |
| Brzymialkiewicz et al. “Evaluation of Fully 3-D Emission Mammotomography With a Compact Cadmium Zinc Telluride Detector”, IEEE Transactions on Medical Imaging, 24(7): 868-877, Jul. 2005. |
| Jan et al. “Preliminary Results From the AROPET”, IEEE Nuclear Science Symposium Conference Record, Nov. 4-10, 2001, 3: 1607-1610, 2001. |
| Ohno et al. “Selection of Optimum Projection Angles in Three Dimensional Myocardial SPECT”, IEEE Nuclear Science Symposium Conference Record 2001, 4: 2166-2169, 2001. |
| Seret et al. “Intrinsic Uniformity Requirements for Pinhole SPECT”, Journal of Nuclear Medicine Technology, 34(1): 43-47, Mar. 2006. |
| Smither “High Resolution Medical Imaging System for 3-D Imaging of Radioactive Sources With 1 mm FWHM Spatial Resolution”, Proceedings of the SPIE, Medical Imaging 2003: Physics of Medical Imaging, 5030: 1052-1060, Jun. 9, 2003. |
| Tomai et al. “A 3D Gantry Single Photon Emission Tomograph With Hemispherical Coverage for Dedicated Breast Imaging”, Nuclear Instruments & Methods in Physics Research, Section A, 497: 157-167, 2003. |
| Advisory Action Before the Filing of an Appeal Brief Dated Feb. 26, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/514,785. |
| Notice of Allowance Dated Feb. 21, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/798,017. |
| Notice of Allowance Dated Feb. 25, 2013 From the US Patent and Trademark Office Re.: U.S. Appl. No. 09/641,973. |
| Communication Under Rule 71(3) EPC Dated Feb. 26, 2013 From the European Patent Office Re. Application No. 06756259.5. |
| Official Action Dated Feb. 22, 2013 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/616,307. |
| Notice of Allowance Dated Mar. 7, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/726,316. |
| Applicant-Initiated Interview Summary Dated Jan. 28, 2013 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/798,017. |
| Official Action Dated Feb. 7, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Notice of Allowance Dated Dec. 26, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 11/980,690. |
| Official Action Dated Dec. 28, 2012 From the US Patent and Trademark Office Re.: U.S. Appl. No. 10/343,792. |
| Charland et al. “The Use of Deconvolution and Total Least Squares in Recovering a Radiation Detector Line Spread Function”, Medical Physics, 25(2): 152-160, Feb. 1998. Abstract Only! |
| Applicant-Initiated Interview Summary Dated Jan. 29, 2014 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/345,773. |
| Communication Pursuant to Article 94(3) EPC Dated Nov. 25, 2013 From the European Patent Office Re. Application No. 06756258.7. |
| Notice of Allowance Dated Dec. 17, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/913,804. |
| Official Action Dated Nov. 15, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/345,773. |
| Official Action Dated Dec. 16, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Communication Pursuant to Article 94(3) EPC Dated Sep. 16, 2013 From the European Patent Office Re.: Application No. 06832278.3. |
| Notice of Allowance Dated Aug. 20, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/932,872. |
| Official Action Dated Aug. 5, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/309,479. |
| Official Action Dated Sep. 5, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 13/947,198. |
| Supplemental Notice of Allowability Dated Aug. 20, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/980,653. |
| Berman et al. “D-SPECT: A Novel Camera for High Speed Quantitative Molecular Imaging: Initial Clinical Results”, The Journal of Nuclear Medicine, 47(Suppl. 1): 131P, 2006. |
| Berman et al. “Myocardial Perfusion Imaging With Technetium-99m-Sestamibi: Comparative Analysis of Available Imaging Protocols”, The Journal of Nuclear Medicine, 35: 681-688, 1994. |
| Borges-Neto et al. “Perfusion and Function at Rest and Treadmill Exercise Using Technetium-99m-Sestamibi: Comparison of One- and Two-Day Protocols in Normal Volunteers”, The Journal of Nuclear Medicine, 31(7): 1128-1132, Jul. 1990. |
| Kwok et al. “Feasability of Simultaneous Dual-Isotope Myocardial Perfusion Acquisition Using a Lower Dose of Sestamibi”, European Journal of Nuclear Medicine, 24(3): 281-285, Mar. 1997. |
| Patton et al. “D-SPECT: A New Solid State Camera for High Speed Molecular Imaging”, The Journal of Nuclear Medicine, 47(Suppl. 1): 189P, 2006. |
| Official Action Dated Apr. 11, 2014 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/309,479. |
| Sharir et al. “D-SPECT: High Speed Myocardial Perfusion Imaging: A Comparison With Dual Detector Anger Camera (A-SPECT)”, The Journal of Nuclear Medicine, 48(Suppl. 2): 51P, # 169, 2007. |
| Applicant-Initiated Interview Summary Dated Mar. 20, 2014 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Official Action Dated Feb. 10, 2014 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Official Action Dated Jul. 30, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 10/343,792. |
| Official Action Dated Jul. 31, 2013 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Communication Pursuant to Article 94(3) EPC Dated May 8, 2014 From the European Patent Office Re. Application No. 05803689.8. |
| Communication Pursuant to Article 94(3) EPC Dated Oct. 10, 2014 From the European Patent Office Re. Application No. 05803689.8. |
| Communication Pursuant to Article 94(3) EPC Dated Oct. 17, 2014 From the European Patent Office Re. Application No. 06809851.6. |
| Communication Pursuant to Article 94(3) EPC Dated Sep. 12, 2014 From the European Patent Office Re. Application No. 06832278.3. |
| Official Action Dated Jun. 17, 2014 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Official Action Dated Jul. 8. 2015 From the US Patent and Trademark Office Re. U.S. Appl. No. 11/667,793. |
| Applicant-Initiated Interview Summary Dated Jun. 11, 2015 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/214,960. |
| Official Action Dated Apr. 15, 2015 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/214,960. |
| Official Action Dated Mar. 26, 2015 From the US Patent and Trademark Office Re. Application No. 14/147,682. |
| Official Action Dated Dec. 4, 2014 From the US Patent and Trademark Office Re. U.S. Appl. No. 12/087,150. |
| Johnson et al. “Analysis and Reconstruction of Medical Images Using Prior Information”, Lectures Notes in Statistics, Case Studies in Bayesian Statistics, II: 149-228, 1995. |
| Official Action Dated Aug. 4, 2015 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/082,314. |
| Official Action Dated Sep. 15, 2015 From the US Patent and Trademark Office Re. U.S. Appl. No. 14/147,682. |
| Number | Date | Country | |
|---|---|---|---|
| 20100142774 A1 | Jun 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60875833 | Dec 2006 | US |
